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ABSTRACT 
 Obesity and its co-morbidities are among the leading health problems 
facing the developed world. Multiple genetic and environmental factors are 
known to have a significant impact on obesity development, however, 
heterogeneity of adipose tissue also contributes to obesity and its complications. 
Regional variation in adipose tissue has been associated with disease risks. For 
example, accumulation of visceral white adipose tissue (VAT), when compared to 
accumulation of subcutaneous white adipose tissue (SAT), is associated with an 
increased risk of diabetes and metabolic syndrome. Accumulation of brown 
adipose tissue (BAT), when compared to accumulation of white adipose tissue 
(WAT), on the other hand, is associated with lower BMI and higher insulin 
sensitivity. The goal of our project is to identify molecular targets that can be 
used as diagnostics, prognostics, or for reprogramming adipose tissue to a 
healthier phenotype (e.g. reprogramming VAT to SAT or WAT to BAT). To this 
  vii 
end, we used three approaches. First, we used metabolic modeling to compare 
brown and white adipocyte metabolic profiles to predict and experimentally 
validate flux differences in the metabolic networks. Through this, we predicted 
and discovered a difference in urea secretion between these two classes of 
adipocytes. Second, we conducted transcriptome analysis of preadipocytes 
derived from SAT and VAT to identify several differentially expressed genes. 
Among them, we focused on Membrane Metallo-Endopeptidase 
(MME/Neprilysin) and showed experimentally that MME regulated the 
inflammatory response and insulin signaling in white preadipocytes by 
differentially affecting the insulin receptor (IR) subunits by increasing IRα but not 
IRβ. Finally, we used single-cell transcriptomics in differentiating human white 
preadipocytes derived from a single adipose depot to identify two subpopulations 
populations and a novel gene cluster of zinc finger proteins involved in white 
preadipocyte differentiation. The results presented here identify several key 
targets underlying the molecular and metabolic heterogeneity of adipose tissue. 
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Introduction 
Obesity is one of the leading health problems in the developed world, creating 
significant health and economic burdens on both individuals and countries. The 
CDC estimates that more than one-third of the adult US population is obese and 
that obesity-related complications are some of the leading causes of preventable 
deaths (Ogden et al., 2012). The estimated medical cost of obesity in the United 
States is approaching nearly $150 billion a year (Kim and Basu, 2016). Certain 
ethnic minority groups are also more at risk for developing obesity and related 
complications including diabetes, cardiovascular disease, and an overall lower 
quality of life (Flegal et al., 2012; Ogden et al., 2014). Thus, there is a need to 
further understand the causes of obesity and obesity-related complications in 
order to form new strategies to combat these growing trends.  
 
From an epidemiological perspective, obesity and its co-morbidities have both 
genetic and environmental inputs. The major environmental factors relate to 
lifestyle and can be treated by lifestyle changes such as diet and exercise. 
However, lifestyle changes have had limited success at an epidemiological level  
(Wadden et al., 2011; The Look AHEAD Research Group, 2013; Lucan and 
DiNicolantonio, 2014). From a pathological perspective, many biochemical, 
molecular, and genetic aspects of obesity have been elucidated and studied. 
Examples include known genetic markers associated with obesity and distinct 
metabolic differences between different fat depots (Beyerlein et al., 2011; Sepe 
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et al., 2011). Additionally, there are several emerging factors proposed to 
influence obesity including the role of the microbiome (Rosenbaum et al., 2015), 
environment-induced epigenetic heritability (Smith and Ryckman, 2015), and 
metabolic complications through viral infections like HIV and other viruses 
(Almgren et al., 2012; Willig and Overton, 2016) . However, one of the biggest 
challenges in this field is integrating how these distinct multi-dimensional 
influences contribute to the obese phenotype. Thus, a greater understanding of 
these emergent properties would potentially allow us to develop more effective 
therapeutic strategies for obesity, diabetes, and related metabolic diseases.  
 
Adipose tissue is the main tissue responsible for energy storage during feeding 
and energy release during periods of fasting. Interfering with the functions of 
adipose tissue results in distinct disease phenotypes including obesity, diabetes, 
and metabolic comorbidities. These functions have different levels of regulation 
and are carried out by specialized types of fat cells and different fat depots, both 
of which have distinct physiological differences. White adipose tissue (WAT) is 
primarily responsible for energy storage, and brown adipose tissue (BAT) is 
responsible for energy expenditure and thermoregulation (Park et al., 2014). 
Among different white fat depots, there are important differences in metabolic 
activity, regenerative capability, links to insulin resistance and potential for 
browning (Sepe et al., 2011; Tchkonia et al., 2013). An increase in visceral 
adipose tissue mass is associated with insulin resistance and diabetes, whereas 
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an increase in subcutaneous adipose tissue mass by surgical transplantation or 
by genetic engineering (e.g. adiponectin) improves metabolic characteristics 
(Ibrahim, 2010; Tran and Kahn, 2010). These observations suggest there are 
intrinsic cellular differences responsible for the regional variation in white adipose 
tissue. A few of the phenotypic differences between visceral and subcutaneous 
adipose tissue are described in Table 1.  
 
Adipocytes are categorized into distinct, phenotypically different groups: white, 
brown, and beige fat cells (Giralt and Villarroya, 2013). Gene expression and 
lineage tracing studies have suggested that these different adipocytes come from 
different preadipocytes (Gesta et al., 2007; Lee et al., 2013a; Sanchez-
Gurmaches and Guertin, 2013; Shan et al., 2013). Preadipocytes, however, are 
difficult to categorize due to the heterogeneous phenotypic differences among 
these cells (Rada et al., 2011; Shan et al., 2013). Additionally, the distinctions 
between adipose-derived stem cells, preadipocytes, and committed 
preadipocytes is often not clear, nor is it clear what the final fate of these cells 
are in vivo (Cawthorn et al., 2012). A more precise characterization of 
preadipocytes would allow us to define these different pools of adipose 
precursors and could elucidate some of the poorly understood, but important 
differences occurring at the cellular level. The underlying causes of these 
observations are unclear and an active area of research. In order to understand 
these differences between different fat tissues, in this thesis, I focused on the 
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primary cell types that comprise fat, i.e. adipocytes and preadipocytes, though it 
worth noting that adipose tissue also contain cells coming from the nervous and 
circulatory systems, which can also contribute to function.  
 
In this thesis, I deploy bioinformatic and bioengineering approaches to gain a 
greater understanding of fat tissue biology and to search for new biomarkers and 
therapeutic strategies for obesity and obesity-related complications. In the first 
chapter, we utilize flux balance analysis and the metabolic profiles of brown and 
white adipocytes to search for global metabolic differences (Ramirez et al., 
2017). In the second chapter, we explore gene expression differences between 
visceral and subcutaneous preadipocytes via high-throughput gene expression 
profiling and subsequent experimental validation where we elucidate the role of 
Membrane Metallo-Endopeptidase (MME) as a regulator of insulin signaling. 
Finally in the third chapter, we elucidate two white adipocyte subpopulations in 
differentiating preadipocytes at the single-cell level and discover a novel cluster 
of zing finger proteins involved in preadipocyte differentiation. Overall, the results 
presented here identify molecular and cellular targets underlying adipose tissue 
heterogeneity that may be utilized for therapeutic strategies in metabolic disease. 
 
  
  
5 
Table 1 Summary of documented phenotypic differences and associations 
in subcutaneous and visceral adipose tissue. 
Observation  Subcutaneous Visceral  Reference 
Process of 
increasing 
adipose mass 
Hyperplasia Hypertrophy 
 (DiGirolamo 
et al., 1998; 
Tchoukalova 
et al., 2010) 
Replicative 
capacity of 
preadipocytes 
High Low  (Tchkonia et al., 2005) 
Rate of fat cell 
formation High Low 
 (Tchkonia 
et al., 2002) 
Lipolysis after 
adrenergenic 
stimulation 
Low High 
 (Hellmer 
and Marcus, 
1992) 
Release of pro-
inflammatory 
cytokines 
Low High  (Fontana et al., 2007) 
Response to 
thiazolidinediones High Low 
 (Adams et 
al., 1997) 
Susceptibility to 
pro-apoptotic 
stimuli 
Low High  (Niesler et al., 1998) 
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Chapter 1: Integrating Extracellular Flux Measurements and Genome-Scale 
Modeling Reveals Differences between Brown and White Adipocytes 
Note: This chapter has been published in Cell Reports (Ramirez et al., 2017). I 
could not have done this work without the help of the co-authors: Matthew Lynes, 
Farnaz Shamsi, Ruidan Xue, Yu-Hua Tseng, C. Ronald Kahn, Simon Kasif, and 
Jonathan Dreyfuss. 
Abstract 
White adipocytes are specialized for energy storage, whereas brown adipocytes 
are specialized for energy expenditure. Explicating this difference can help 
identify therapeutic targets for obesity. A common tool to assess metabolic 
differences between such cells is the Seahorse Extracellular Flux (XF) Analyzer, 
which measures oxygen consumption and media acidification in the presence of 
different substrates and perturbagens. Here, we integrate the Analyzer’s 
metabolic profile from human white and brown adipocytes with a genome-scale 
metabolic model to predict flux differences across the metabolic map. Predictions 
matched experimental data for the metabolite GABA, the protein ABAT, and the 
fluxes for glucose, glutamine, and palmitate. We also uncovered a difference in 
how adipocytes dispose of nitrogenous waste, with brown adipocytes secreting 
less ammonia and more urea than white adipocytes. Thus, the method and 
software we developed allow for broader metabolic phenotyping and provide a 
unique approach to uncovering metabolic differences. 
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Graphical Abstract 
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Introduction 
Adipose tissue is critical for maintenance of metabolic homeostasis through its 
effects on energy balance and its endocrine function (Tran and Kahn, 2010). 
Adipose is capable of expanding and remodeling to meet a wide range of 
metabolic challenges by increasing the number, size and activity of adipocytes 
(Hyvönen and Spalding, 2014). Adipocytes can be broadly divided into three 
metabolically-distinct types: white, brown, and beige adipocytes (Giralt and 
Villarroya, 2013). White adipocytes are energy storing cells characterized by 
large unilocular lipid droplets (Tchkonia et al., 2013). Brown adipocytes have 
multilocular fat droplets and are involved in expending energy for thermogenesis 
via uncoupled respiration, which is mediated by the inner mitochondrial 
membrane protein uncoupling protein 1 (UCP1) (Cannon  J., 2004). Beige 
adipocytes also express UCP1 and are found dispersed in white adipose depots 
where they can be induced to burn energy to generate heat like brown 
adipocytes (Sanchez-Gurmaches and Guertin, 2013). Although it had been 
thought that brown adipose tissue was present in humans only in infancy, we and 
others have shown that brown adipose tissue is present in adult humans and is 
correlated with lower BMI and lower fasting glucose levels (Cypess et al., 2009, 
2013).  
 
Activation of brown adipose tissue or increasing brown adipose mass in murine 
models has been shown to improve glucose metabolism, increase energy 
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expenditure, reduce hypercholesterolaemia (Berbée et al., 2015), and protect 
against obesity (Harms and Seale, 2013). Similarly, activation of brown adipose 
in humans with type 2 diabetes via cold exposure can improve insulin sensitivity 
(Hanssen et al., 2015), and improved insulin sensitivity is a feature of increased 
protection against diabetes and its complications and co-morbidities such as 
cancer, heart disease and Alzheimer’s (Orgel and Mittelman, 2013; Laakso and 
Kuusisto, 2014). Pharmacological activation of human beige and brown adipose 
tissue is therefore being explored as a potential therapy for human obesity 
(Cypess et al., 2015), and it is critical to gain better insight into the metabolic 
differences between brown and white adipocytes to elucidate the full set of 
potential targets responsible for the beneficial effects of brown adipose tissue 
(Tseng et al., 2010). 
 
The ideal method to characterize the brown and white adipocyte metabolic 
profiles would be via genome-scale experimental metabolic flux analysis, e.g. 
(Quek et al., 2010), but this is experimentally challenging. An increasingly 
popular technique to assess metabolic differences in vitro between cells of 
different types or in different conditions is to measure extracellular fluxes of 
metabolites like oxygen, carbon dioxide, and lactate. For example, the Seahorse 
XF Analyzer can be used to measure oxygen consumption rate (OCR) and pH 
change, which is read out as extracellular acidification rate (ECAR) or proton 
production rate (PPR), in the presence of different substrates or perturbagens to 
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estimate mitochondrial respiration and glycolysis. The Seahorse Analyzer has 
been used in thousands of studies, including with isolated adipose tissue, 
preadipocytes, and adipocytes (Gesta et al., 2011; Xue et al., 2015). 
 
Metabolic fluxes can be modeled in silico via a technique called flux balance 
analysis (FBA) (Orth et al., 2010). In this framework, each metabolite’s input and 
output fluxes balance, i.e. equalize, so that the metabolite’s concentration is 
steady. FBA represents a metabolic network with a stoichiometric matrix that 
captures the stoichiometric coefficients of each biochemical reaction as a column 
of the matrix, where each matrix row represents a metabolite. The fluxes are 
bounded by lower and upper bound constraints, respectively, that encode 
constraints such as reaction directionality and limited nutrient uptake. Together, 
the stoichiometric matrix and lower and upper bounds define the feasible flux 
configurations at steady state via linear constraints, which can be solved 
efficiently. Moreover, if a cellular objective, such as ATP synthesis, is postulated, 
it can be maximized subject to the constraints to yield an optimal flux 
configuration. 
 
Genome-scale metabolic network models have been constructed for over 100 
organisms, from bacteria to fungi to human cells (Feist et al., 2009; Dreyfuss et 
al., 2013). Some models have been made for specific human tissue and cell 
types. For example, the white adipocyte model iAdipocyte1809 has been used to 
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elucidate metabolic differences between lean and obese states (Mardinoglu et 
al., 2013, 2014) and before and after weight loss (Mardinoglu et al., 2015). 
However, we did not use iAdipocyte1809 or its successor iAdipocytes1850, 
because we wanted to be able to uncover brown adipocyte specific metabolic 
reactions. Thus, we began with the human generic genome-scale metabolic 
model Recon 2.1x, an update to Recon 2 (Thiele et al., 2013) where all the 
reactions are elementally-balanced, which makes the model suitable for FBA 
(Smallbone, 2013; Quek et al., 2014; Sahoo et al., 2015).  
 
Prior studies have shown the potential of connecting extracellular measurements 
with FBA (Munger et al., 2008; Mo et al., 2009; Si et al., 2009; Frezza et al., 
2011; Fan et al., 2013, 2014; Kaplon et al., 2013; Aurich et al., 2015), but thus 
far, FBA has not been systematically integrated with Seahorse Analyzer 
metabolic profiling to predict the full range of intracellular fluxes. Figure 1A 
illustrates that the Seahorse Analyzer directly measures several fluxes; by 
addition of chemical perturbations it indirectly measures several more (explained 
in Figure 1B); and, although only a selected few other fluxes are drawn, the rest 
of the fluxes stretching across the metabolic network can potentially be inferred 
from integration with FBA. In this work, we show that by integrating Seahorse 
measurements with genome-scale FBA we can infer flux differences in substrate 
uptake and, more importantly, across the metabolic map between white and 
brown adipocytes. We then compare these predicted differences to publically 
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available data and measure selected predicted fluxes experimentally to identify 
differences in clinically and physiologically relevant metabolic pathways. 
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Methods 
Cell culture maintenance and differentiation of human white and brown 
preadipocytes 
Human immortalized white and brown preadipocyte cell lines were obtained from 
normal subjects and cultured as previously described (Xue et al., 2015; Kriszt et 
al., 2017). Briefly, cells were maintained in DMEM-H, 10% FBS, 1% Pen-Strep 
(100 U/mL), and 0.2% normocin (100 ìg/mL). For differentiation, cells were 
plated in growth media (day 0) and treated with pre-induction media (DMEM-H, 
2% FBS, 1% Pen-Strep, 0.2% normocin, 500 nM insulin, 2 nM T3, 1 μM 
rosiglitazone) for 6 days (days 1-6). Cells were then treated with differentiation 
media (DMEM-H, 2% FBS, 1% Pen-Strep, 0.2% normocin, 500 nM insulin, 500 
μM IBMX, 2 nM T3, 1 μM rosiglitazone, 33 μM biotin, 17 μM pantothenate, 100 
nM dexamethasone, and 30 μM indomethacin) for 14 days (days 7-20). Insulin, 
IBMX, rosiglitazone, T3, biotin, pantothenate, dexamethasone, indomethacin, 
and FBS were obtained from Sigma-Aldrich. Penicillin-streptomycin and 
normocin were obtained from Fisher Scientific. DMEM-H was prepared by the 
Joslin Diabetes Center Media Core and formulation is provided in Table 2. 
 
Arginase inhibition during differentiation 
Differentiation was carried out in the presence of 2(S)-Amino-6-boronohexanoic 
acid hydrochloride (ABH, Sigma-Aldrich) at 0 μM (water), 1 μM, or 10 μM in both 
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the pre-induction and induction phase. At day 20, RNA was extracted via the 
Qiagen RNAeasy mini kit (Qiagen). Complementary DNA synthesis was 
performed with 200 ng/sample of RNA via the High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems). Quantitative PCR was performed via the 
SYBR Green PCR Master Mix (Bio-Rad) on the CFX384 Real-Time PCR 
Detection System according to the manufacturer’s protocol. Expression was 
normalized to the reference gene HPRT1. 
 
Microarray analysis of preadipocytes 
We measured global gene expression patterns by microarray from paired brown 
and white preadipocytes from four individuals. However, a microarray from one 
person did not pass quality control, so we performed a paired analysis with three 
individuals. Analysis of gene expression using GeneChip PrimeView (Affymetrix, 
Santa Clara, CA) was performed on white and brown cell lines. RNA was isolated 
from clonal cell lines using Direct-zol RNA miniPrep kit (Zymo Research, Irvine, 
CA) according to the manufacturer's instructions. The quality of total RNA was 
evaluated by A260/A280 ratio. Biotin-labeled cRNA was synthesized, purified and 
fragmented using GeneChip 3’ IVT Express Kit (Affymetrix, Santa Clara, CA). 
Integrity and fragmented cRNA was assessed by running aliquots on the Agilent 
2100 Bioanalyzer before proceeding further. As one hWAT-SVF had poor quality, 
this sample and its paired hBAT-SVF was excluded from analysis. Array 
hybridization and scanning were performed by the Advanced Genomics and 
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Genetics Core of Joslin Diabetes Center. Microarray data were normalized using 
robust multiarray average (RMA) and were deposited to the GEO repository 
(accession number GSE100003). Paired differential expression analysis between 
brown and white samples was performed in limma. All microarray analyses were 
done in the R software (www.r-project.org). 
 
Seahorse XF Analyzer measurements of brown and white adipocytes 
Oxygen consumption and extracellular acidification rates were measured in 
differentiated brown and white adipocytes using the Agilent Seahorse XF24 
Extracellular Flux Analyzer. Briefly, preadipocytes were seeded at 50,000 
cells/well in 24-well assay plates and allowed to adhere overnight. Adipogenic 
differentiation was carried out for 20 days as described above. For the flux assay, 
pyruvate (1 mM final concentration), oligomycin (1 μM), FCCP (4 μM), and 
rotenone (5 μM) were sequentially added at the indicated times. Flux values were 
normalized to DNA content. DNA was isolated with 100 μL/well of 50 mM NaOH, 
incubated for 30 minutes at room temperature, heated at 96° C for 5 minutes, 
neutralized with 25 uL 1 M Tris-HCl, and measured via a Nanodrop. 
 
Nova BioProfile FLEX Analyzer measurements 
Brown and white preadipocytes were seeded at 200,000 cells/well in 6-well 
plates (~22,000 cells/cm2) and differentiated for 20 days. Cells were washed with 
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PBS and Assay media (DMEM-H, 1% pen-strep, 0.2% normocin, 2 mM 
glutamine, 25 mM glucose) was added at 2 mL/well. Conditioned media was 
collected at 0, 24, and 48 hrs, centrifuged at 1000 X g to remove cellular debris, 
and stored at -80° C until assay. Samples were thawed on ice and assayed on 
the Nova Analyzer to measure the concentrations of glucose, glutamine, lactate, 
glutamate, ammonia, potassium, and sodium (Figure S3). For normalization, total 
protein was collected with protein lysis buffer (RIPA, 0.1% SDS, 1X protease and 
phosphatase inhibitor cocktail (Bimake)) and quantified with a bicinchoninic acid 
(BCA) assay (ThermoFisher). Fluxes were calculated from the 48-hr 
measurements compared to the 0-hr measurements. 
 
GABA measurement and ABAT immunoblotting 
A total of 50 μL/sample of conditioned media or diluted protein lysate (1:5 
dilution) were loaded onto a 96-well ELISA plate for GABA quantification. GABA 
levels were measured with an ELISA kit according to the manufacturer’s protocol 
(LifeSpan Biosciences). For SDS-PAGE, 10 ug/sample of prepared protein (cell 
lysate with 1X LDS sample buffer) were run on a 4-12% Bis-Tris polyacrylamide 
gel at 120 V for 60 min in 1X running buffer (2.5 mM MOPS, 2.5 mM Tris base, 
0.005% SDS, 50 μM EDTA, pH 7.7). Protein was then transferred to PVDF 
membrane at 30 V for 960 minutes in 1X transfer buffer (1.25 mM Bicine, 1.25 
mM Bis-Tris, 50 μM EDTA, pH 7.2). Membranes were blocked in Starting Block 
T20 (ThermoFisher). Primary antibodies were used at a 1:2000 dilution (ABAT 
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(Abcam), Actin (Santa Cruz), and Complex V (mitoprofile cocktail from 
Mitosciences)). Secondary antibodies were used at a 1:5000 dilution (anti-mouse 
(Bio-Rad) or anti-rabbit (Bio-Rad)). Signal was detected by Pico 
Chemiluminescent Substrate (ThermoFisher). 
 
Recon 2.1A Reconstruction and Validation 
Recon 2.1x was obtained from the Biomodels database under the identifier 
MODEL1311110001. Like all metabolic modeling performed in this work, 
analyses were performed on the Boston University Shared Computing Cluster 
(Linux CentOS 10.6), flux balance analysis (FBA) calculations were performed in 
the R package Sybil, and optimizations were performed using IBM ILOG CPLEX 
v12.6.1. The canonical fluxes of central metabolism were drawn using the 
visualization tool Escher (King et al., 2015). 
 
Assessment of statistically significant flux differences between brown and white 
adipocytes  
We wanted to calculate a flux distribution for each of brown and white adipocytes 
in Recon 2.1A from the input data – which consisted of the Seahorse Analyzer 
data, with or without the Nova Analyzer data – and then to compare brown and 
white adipocytes statistically. We applied this calculation to one representative 
set of immortalized cell lines of three (each set from a different individual) that 
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were performed experimentally. We chose the paired cell line set with the largest 
changes to most easily distinguish brown vs. white differences. To allow 
statistical testing from this cell line, we sampled from our input data. For our 
Seahorse data, we focused on the last time point of each injection. We: 
1. Estimated the mean and standard deviation of each flux in the input 
data, such as oxygen consumption rate 
2. Sampled from Normal distributions with mean and standard deviations 
from Step #1 via the R function rnorm until we had approximately 150 
feasible input flux configurations 
3. Constrained Recon 2.1A based on each sampled input flux (see 
Constraining Recon 2.1A reactions with Seahorse and Nova Analyzer 
data) 
4. Maximized the lipid profile of each adipocyte only when we had the 
additional Nova Analyzer measurements to further constrain the 
model, as it was in this case that the lipid maximization achieved best 
results in terms of matching experimental data 
5. Minimized total flux. If we had maximized the lipid profile in Step #4, 
minimizing total flux was a secondary optimization 
This gave a flux distribution for each of brown and white adipocytes. To compare 
these distributions statistically, we: 
6. Applied the Student’s t-test to each reaction, using the R function t.test, 
to calculate a p-value for each reaction 
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7. Corrected the p-values for multiple testing using a false discovery rate 
(FDR) method that allows for arbitrary dependence between tests 
(Benjamini and Yekutieli, 2001), since many of the fluxes are linearly 
dependent.  
 
Prediction of flux differences between brown and white adipocytes using FVA 
To identify if a reaction’s flux range is non-overlapping between brown and white 
adipocytes given both Seahorse and Nova Analyzer data, we:  
1. Constrained Recon 2.1A based on the input fluxes  
2. Maximized the lipid profile of each adipocyte 
3. Applied flux variability analysis (FVA) using Sybil to get the range of 
each reaction’s flux in each of brown and white adipocytes given the 
constraints from Step #1 and the maximum from Step #2 
4. Performed reaction set enrichment using the Fisher’s exact test on the 
list of non-overlapping fluxes revealed by FVA. 
 
Constraining Recon 2.1A reactions with Seahorse and Nova Analyzer data 
To integrate OCR, Proton Production Rate (PPR), and the inferred intracellular 
fluxes from perturbagens, the measured fluxes were mapped to their 
corresponding reactions in the model. A total of five different reactions were 
constrained from the measurements of the Seahorse oxidative stress test. 
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Oxygen and proton exchange were set to basal OCR and basal PPR, 
respectively. Mitochondrial respiration was set to the difference between basal 
OCR and non-oxidative OCR (OCRrotenone). Mitochondrial ATP synthase activity 
was set to the P/O ratio (Hinkle, 2005) times the difference in basal OCR and 
ATP-synthase-inhibited OCR (OCRoligomycin). Proton leak was set to the difference 
between ATP-synthesis-inhibited OCR and non-oxidative OCR. 
 For fluxes that were not measured and whose metabolites were present in the 
assay media, the upper bound was estimated by the media concentration (Table 
2)(Aurich et al., 2015). While the concentration of nutrients in the media might 
change during the course of the assay, the assumption was that media nutrients 
would not be exhausted by the end of the assay (3 hrs) (see below for a more 
explicit derivation).  
 
To convert the units of the measurements (pmol/min/ug protein or pmol/min/ug 
DNA) to the units of the model (mmol/gDw/hr), we estimated 2.6% of dry weight 
was protein (Bonarius et al., 1996). Next, 700 μL/well of nutrient media was 
available to 50,000 cells/well. The weight of a single adipocyte was estimated to 
be 20 ng, the DNA weight to be 7 pg, and the dry weight was estimated to be 
80% of the total weight (Milo et al., 2009).  
 
Fluxes calculated from the Nova Analyzer data were integrated similarly. 
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Comparison of gene expression between brown and white adipose tissue and 
predicted fluxes 
Brown and white adipose tissue gene expression profiles were obtained from 
NCBI GEO GSE27657. Gene expression matrices were parsed with the R 
package GEOquery and differential gene expression was performed with limma.  
To associate a gene expression level with each metabolic reaction, for each 
reaction we calculated the mean log2 fold change between brown and white 
adipose tissue for all associated genes. To compare gene expression differences 
vs. predicted flux differences, for each reaction the mean log2 fold change of 
gene expression (log2FCgene) was compared against the log2 fold change in 
magnitude of predicted reaction flux (log2FCreaction). Instances where the 
log2FCreaction was undefined (e.g. 0/0) were removed. 
 
Theoretical maximum uptake of nutrients from media concentrations 
x = media concentration 
700 uL = Final volume of the assay 
50000 cells = Approximate number of cells/well 
20 x 10-9 g = weight of a single adipocyte 
.8 g / 1 gDw = 20% water content in adipocytes. 
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3 hrs = Duration of assay 
Converting palmitate uptake to model units 
Specific activity of 14C-Palmitate = 60 mCi/mmol 
Ratio of Cold:Hot Palmitate = 500 uM / 0.0033 uM = 151515 
x = counts per minute (CPM) 
y = protein amount (ug Protein) 
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Results 
Reconstruction and validation of the human genome-scale metabolic model 
Recon 2.1A 
We began with Recon 2.1x and applied a series of tests to determine whether 
this genome-scale metabolic model would produce biologically feasible results 
for white and brown adipocytes, particularly with regards to central carbon 
metabolism and energy utilization. As we applied these tests, we found that we 
could improve upon Recon 2.1x to give more quantitatively realistic results. 
Therefore we implemented an iterative process from a reconstruction protocol  
(Thiele and Palsson, 2010) to revise Recon 2.1x and termed the final revised 
model, Recon 2.1A. For example, we tested if Recon 2.1x would produce 
biomass only in the presence of all essential nutrients by blocking external 
metabolites present in the Seahorse media one at a time. As seen in Figure S1, 
Recon 2.1x correctly predicted nearly all of these metabolites except 
phenylalanine, which is an essential amino acid (Figure S1C). We corrected this 
prediction in Recon 2.1A (Figure S1D). Other examples of our revision are that 
Recon 2.1A can produce realistic amounts of ATP given carbon sources of 
different lengths (Coles et al., 2013)(Figure S1E), and that Recon 2.1A supports 
flux through all the canonical fluxes of central carbon metabolism (Figure S2). 
Overall, these changes to the model (listed in Table 5) had a systemic impact on 
the flux bounds of thousands of reactions in Recon 2.1A (Figures S1A and S1B). 
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Integrating Seahorse XF Analyzer metabolic flux profiles with Recon 2.1A 
enables accurate assessment of flux differences 
To generate metabolic profiles for brown and white adipocytes, we performed an 
oxidative stress test using the Seahorse XR24 Analyzer. Using medium 
containing glucose (25 mM) and several amino acids as substrates (Table 2), 
brown adipocytes had a basal oxygen consumption rate (OCR) 9-fold higher than 
white adipocytes (Figure 2A), consistent with their known differences in energy 
expenditure compared to energy storage (Xue et al., 2015). The basal proton 
production rate (PPR), a measure of glycolytic activity, was higher in brown 
adipocytes compared to white adipocytes (Figure 2B). The addition of pyruvate 
(1 mM) did not change OCR or PPR in either brown or white adipocytes. Based 
on the perturbation data, brown adipocytes had higher ATP production and 
proton leak compared to white adipocytes (Figure 2C). The spare respiratory 
capacity was 8-fold higher in brown adipocytes than white adipocytes. Lastly, the 
non-mitochondrial OCR was 10-fold higher in brown adipocytes than in white 
adipocytes. We used these measurements to estimate representative normal 
distributions given a mean and standard deviation, and then sampled from these 
distributions to produce one set of constraints for brown adipocytes and one set 
for white adipocytes. For non-measured exchange fluxes, we estimated the 
upper bounds from empirical principles. For each set of sampled constraints, we 
then minimized total flux (Holzhütter, 2004).  
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Figure 2D-G shows the significant (FDR < 0.05) predicted flux differences 
between brown and white adipocytes for a carbohydrate (glucose), an amino acid 
(glutamine), a free fatty acid (palmitate) and a waste metabolite (ammonia). The 
model predicted higher substrate utilization in brown compared to white 
adipocytes for glucose, glutamine, and palmitate as well as higher secretion of 
ammonia, as a waste product of amino acid (arginine) metabolism. 
 
To validate these flux predictions made by the model, we analyzed cells with the 
Nova BioProfile FLEX Analyzer, which assessed concentrations of seven 
extracellular metabolites (Figure S3). Consistent with FBA-derived predictions, 
uptake of glucose and glutamine was higher in brown compared to white 
adipocytes (Figure 2H and 2I). Similarly, previous measurement of palmitate 
uptake (Xue et al., 2015) using radiolabeled palmitate was shown to be higher in 
brown than white adipocytes (Figure 2J). While the metabolic model did not 
predict a difference for sodium and potassium uptake, uptake of both were 
significantly higher in brown than white adipocytes (Figure S3). The 
measurements for glutamate and lactate were below the instrument detection 
limit (Figure S3). Although the magnitudes of the predicted fluxes were different 
from the measured values, the pattern of predicted and measured fluxes was 
consistent (Figure S4). However, inconsistent with the metabolic model’s 
prediction, white adipocytes had higher ammonia secretion than brown 
adipocytes (Figure 2K). 
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Brown compared to white adipocytes have lower ammonia secretion despite a 
higher metabolic demand 
The difference in ammonia secretion between our experiments and the 
predictions by our model was unexpected. We therefore sought to identify the 
metabolic reactions responsible for this discrepancy. We first constrained the 
ammonia, glutamine, glucose, and palmitate fluxes to their measured values. We 
then matched the mathematical objectives to the known biology by using the 
different lipidomic profiles of brown and white adipose tissue (Hoene et al., 2014) 
to create brown and white-specific lipid objective functions. To construct these 
objectives, the lipids species were coalesced into 10 major lipid classes: 
ceramides, diglycerides, triglycerides, free fatty acids, phosphotidylcholines, 
phosphotidylethanolamines, phosphotidylglycerols, phosphotidylserines, 
phosphotidylinositols, and sphingomyelins (Table 3). These objectives more 
accurately reflect the lipid composition of adipose tissue rather than the lipid 
droplet objective from iAdipocytes1809 and iAdipocytes1850, which was based 
on isolated lipid droplets from Chinese hamster ovary (CHO) cells (Table 6). 
These objectives were then maximized to yield new tissue-specific fluxes.  
 
Since ammonia is a byproduct of amino acid catabolism (Walker, 2009), we then 
compared brown and white adipocyte fluxes in amino acid metabolism. This 
comparison suggested that the largest differences in amino acid metabolism 
would involve ornithine-related pathways (Figure 3A) and potentially urea 
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secretion (Figure 3B). Thus, to determine if brown compared to white adipocytes 
may preferentially secrete excess nitrogenous waste as urea instead of 
ammonia, we examined a gene expression dataset (GEO GSE27657) comparing 
brown to white adipose tissue (Svensson et al., 2011) and found a 3-fold higher 
expression of arginase 2, the enzyme that catalyzes the formation of urea and 
ornithine (Figure 3C). We directly measured urea flux and, consistent with the 
difference in gene expression, urea secretion was higher in brown compared to 
white adipocytes (Figure 3D). Brown adipocytes, but not white adipocytes, 
showed a dose-dependent response of ADIPOQ and UCP1 to the arginase 
inhibitor ABH during adipogenesis (Figure 3E), suggesting a functional 
importance of urea production specific to brown adipocytes. 
 
Integrating Seahorse and Nova Analyzer profiles with Recon 2.1A enables 
prediction of flux differences 
After optimizing the lipid profiles subject to the constraints of flux balance, 
nutrient uptake, and extracellular flux measurements, some reactions could still 
carry a range of flux. Thus, under these conditions, we applied flux variability 
analysis (Mahadevan and Schilling, 2003) (FVA) to probe the maximum and 
minimum feasible flux every reaction could carry in brown or in white adipocytes. 
FVA yielded 85 reactions with non-overlapping flux ranges between brown and 
white adipocytes (Table 4). Figure 4A illustrates the top 30 non-overlapping 
ranges of these reactions. The non-overlapping fluxes were enriched in 
  
28 
metabolic pathways largely related to central metabolism and metabolism of 
specific amino acids (Figure 4B). Each non-overlapping reaction is likely to have 
a role in distinguishing brown and white adipocytes, such as 4-aminobutyrate 
(GABA) transaminase (Figure 4C). GABA, one of the reactants of this reaction, 
was found to be higher in brown adipocyte lysates (Figure 4D). The enzyme 
catalyzing this reaction, ABAT, has significantly higher protein levels in brown 
adipocytes (Figure 4E). While the role of GABA in adipocytes is unclear, ABAT 
has been shown to be essential for mitochondrial nucleoside metabolism (Besse 
et al., 2015). 
 
Key metabolic fluxes are concordant with preadipocyte and adipocyte gene 
expression 
To further validate fluxes differentially active in brown and white adipocytes, we 
measured global gene expression patterns by microarray from paired brown and 
white preadipocytes. Then we sought indications of what fluxes are likely to be 
different based on what genes were differentially expressed at a threshold of 
FDR=0.15 (van Berlo et al., 2011). We found 35 unique genes significant at this 
FDR (see https://github.com/jdreyf/pread-brown-white for all probes’ statistics), 
however only one of these was associated with a reaction in the model that could 
carry flux in the Seahorse media: adenylate kinase 4. We can only enforce 
constraints on reactions that require this gene, but according to the model the 
reactions associated with adenylate kinase 4 can also utilize its isozymes such 
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as adenylate kinase 2, so this microarray dataset did not allow for any model 
reaction constraints. However, we did find that the gene ABAT was nominally 
significantly upregulated in brown preadipocytes (p=0.04). 
 
Although the association between gene expression and metabolic flux is 
generally weak and varies depending on the subsystem (which is akin to a 
pathway) under study (Chubukov et al., 2013), we took a second gene 
expression approach to validate our model. We compared predicted flux 
differences to the differences in associated gene expression between brown and 
white adipose tissue from the gene expression dataset GEO GSE27657. We 
observed high concordance between the direction of gene expression change 
and the direction of predicted flux magnitude change in several subsystems, 
including the citric acid cycle, cholesterol metabolism, and branched-chain amino 
acid (BCAA) metabolism (Figure S5). Many of these results are largely consistent 
with the significant subsystems revealed by enrichment of the non-overlapping 
fluxes without gene expression (Figure 4B), but a few subsystems are not 
consistent, such as histidine and methionine/cysteine metabolism. 
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Discussion 
Several advances were made in this work. First, we reconstructed Recon 2.1A 
such that it was suitable for FBA by revising Recon 2.1x. Recon 2.1x is a revision 
of Recon 2 that has substantially more lipid metabolism reactions (Smallbone, 
2013), but we had to revise Recon 2.1x due to several key biologically unrealistic 
predictions, such as unreasonably high ATP production with limited oxygen and 
nutrients. During the time we were working on this project, Recon 2.2 was 
published (Swainston et al., 2016). However, Recon 2.2 is not based on Recon 
2.1x, thus, Recon 2.2 is less comprehensive regarding lipid metabolism important 
to brown and white adipocytes. 
 
Secondly, and more importantly, the results presented here demonstrate that in 
adipocytes many fluxes can be sufficiently constrained to reveal intracellular 
metabolic differences from measurements of oxygen consumption and 
extracellular acidification when the nutrient media is known. Knowledge of the 
nutrient media allowed us to bound uptake by assuming that nutrients were not 
depleted from the media over the three-hour assay interval. If this assumption 
was flawed, it could explain why Recon 2.1A could not produce feasible solutions 
when integrating the sodium or potassium flux measurements. The other 
potential reason is that some reactions involving potassium and sodium in the 
model may be incorrect, e.g. the model may need additional co-transport 
reactions for each of potassium and sodium. 
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The brown and white adipose tissue substrate preference for energy utilization 
and adipose tissue development is unclear (Montanari et al., 2017). Higher 
uptake of glucose, glutamine, and palmitate was measured in brown adipocytes 
compared to white adipocytes, which is consistent with the notion that higher 
energy expenditure is accompanied with higher overall substrate flux. In contrast, 
ammonia secretion, one of the metabolites of amino acid catabolism, was higher 
in white adipocytes. We find that this discrepancy is resolved by the observation 
that brown adipocytes have higher rates of urea production. The higher secretion 
of urea may be due to higher levels of arginase-2 (ARG2), a mitochondrial 
arginase isozyme known to be involved in pathways beyond ureagenesis 
including the synthesis of polyamines (Wu and Morris, 1998), which are critical 
for adipogenesis (Brenner et al., 2015). Arginine, the substrate for ARG2 that is 
converted to urea and ornithine, has been suggested to increase brown adipose 
tissue activity (McKnight et al., 2010). Differentiating preadipocytes treated with 
the arginase inhibitor ABH increased UCP1 and ADIPOQ expression in brown 
adipocytes, but not white adipocytes. Thus, flux through ARG2 in brown adipose 
tissue has functional importance and may be a target to shift the metabolic profile 
to a more brown-like state. 
 
Many methods have been developed to infer flux from common omics 
technologies by integrating with genome-scale modeling (Shlomi et al., 2008; 
Lewis et al., 2012), but the data from these technologies has only a weak 
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association to flux, whereas extracellular flux measurements directly constrain 
the flux space. After accounting for constraints from the nutrient media, 
incorporating Seahorse measurements affects the bounds of over 10,000 
reactions. In contrast, to properly estimate a reaction’s flux from non-flux data, 
one needs kinetic parameters and quantitative estimates of the concentrations of 
active enzyme and all products and reactants. Gene expression from microarrays 
or RNA-seq, for example, falls short of this. The weak association between gene 
expression and flux is one reason we did not use gene expression to reconstruct 
brown and white adipocyte specific models; another reason is that gene 
expression datasets are context-specific, whereas cell-type specific models 
ought to include the reactions a cell can carry out in any context. Even though we 
did not reconstruct a cell-type specific model, we still selected an objective for 
modeling despite this being a known challenge for human cells. Adipocytes, 
under certain conditions (Berry et al., 2014), are lipid-laden cells whose 
expansion is characterized by de novo lipogenesis, thus we defined a lipid 
objective. Combining this objective with network-wide gene expression can point 
to more likely flux configurations, though, and it is reassuring that in key 
pathways, such as the citric acid cycle, where expression and flux were 
concordant in lower organisms (Chubukov et al., 2013), gene expression 
differences of brown compared to white adipocytes are consistent with our 
predicted flux differences.  
 
  
33 
One strategy to metabolically reprogram white adipocyte metabolism to more 
closely resemble that of brown adipocytes is to target UCP1 activity (Xue et al., 
2015), but here we identify many other enzymes that catalyze reactions likely to 
be different between white compared to brown adipocytes, which are also 
candidate targets for reprogramming. More generally, one could search for 
candidate reactions for metabolic reprogramming between any two metabolic 
profiles. Going forward, the combination approach of metabolic flux profiling and 
quantitative flux modeling described here can be applied to other tissues, such 
as liver, brain, and skeletal muscle (Bordbar et al., 2011; Gavai et al., 2015; 
Nogiec et al., 2015), and it can similarly be extended to any cell type assayed 
with extracellular analyzers, such as cancer vs. normal cells, stem cells vs. 
differentiated cells, and treated vs. untreated cells. Thus, we have released a 
freely available R software package, sybilxf, based on the R package Sybil 
(Gelius-Dietrich et al., 2013), to perform metabolic modeling and search for 
predicted differences between metabolic profiles produced by the Seahorse 
Analyzer. 
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Figures 
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Figure 1 Schematic representation of integrative modeling. (A) The 
Seahorse XF Analyzer directly measures oxygen consumption rate (OCR) and 
extracellular acidification rate / proton production rate (ECAR/PPR) (red), 
indirectly measures intracellular fluxes through chemical perturbations such as 
oligomycin and rotenone (green), other fluxes are modeled via metabolic 
modeling and may be predicted (selected fluxes shown in black). (B) Table 
explaining how indirectly measured fluxes are calculated from Seahorse 
measurements. See also Table 7. 
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Figure 2 Measured, predicted, and validated fluxes on brown and white 
adipocyte Seahorse extracellular flux profiles. Oxygen consumption rates (A) 
and proton production rates (B) were measured in response to pyruvate, 
oligomycin (an ATP synthase inhibitor), FCCP (a mitochondrial de-coupler), and 
rotenone (a Complex I inhibitor). Brown adipocytes (black), compared to white 
adipocytes (white), showed significantly higher rates of oxygen consumption and 
extracellular acidification (proton production) under every injection. (C) Indirectly 
measured fluxes as revealed by differences in oxygen consumption rates. These 
extracellular flux profiles of brown and white adipocytes were integrated into the 
model by sampling from the data and minimizing total flux. The model predicted 
higher glucose, glutamine, and palmitate uptake and higher ammonia secretion 
for brown adipocytes (D-G). Experimentally measuring these metabolites showed 
consistent results for glucose, glutamine, and palmitate (H-J), but not for 
ammonia (K). Bars indicate mean ± s.e.m. Seahorse measurements were 
normalized to DNA; Nova measurements were normalized to protein; units were 
converted to dry weight. See also Figures S3 and S4. 
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Figure 3 Amino acid metabolism in brown and white adipocytes. (A) The 
differences between brown and white predicted fluxes in amino acid catabolism. 
Red = higher in brown adipocytes, blue = higher in white, black = neither brown 
nor white adipocytes carried flux through those reactions. (B) The model 
predicted higher secretion of urea. (C) Gene expression showed approximately a 
3-fold higher expression of arginase 2 in brown adipose tissue compared to white 
adipose tissue. (D) Urea flux was higher in brown adipocytes compared to white 
adipocytes. Bars indicate mean ± s.e.m. (E) Inhibiting arginase activity via the 
chemical ABH altered several key adipogenic genes in brown adipocytes, but not 
white adipocytes. 
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Figure 4 Reactions predicted to have non-overlapping flux ranges between 
brown and white adipocytes. (A) Top 30 reactions as revealed by flux 
variability analysis whose predicted extrema did not overlap between brown and 
white adipocytes. See also Table 4. (B) The non-overlapping reactions were 
enriched in pathways related to central metabolism and amino acid metabolism, 
as shown by their -log10(FDR). See also Figure S5, where flux predictions are 
compared to gene expression by pathway. These reactions are likely to have 
some distinguishing role in brown and white adipocyte biology, such as 4-
aminobutyrate transaminase (C) in mitochondrial maintenance. The reactant 
metabolite GABA (D) and the catalyzing gene ABAT (E) were found to be higher 
in brown adipocytes. Bars indicate mean ± s.e.m. 
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Figure S1 Validating Recon 2.1A with experimental observations. Flux 
variability analysis was used to determine the bounds of each reaction and 
averaged into subsystems under the absence (A) or presence (B) of complete 
growth media. FVA in Recon 2.1A (red) revealed the flux capacity of 26 
subsystems representing over 100 reactions changed in the absence of media 
(A) and the flux capacity of 74 subsystems representing over 10000 reactions in 
the presence of every exchange reaction compared to FVA in Recon 2.1x 
(black). (C) External metabolites present in the Seahorse assay media were 
blocked one at a time and biomass was maximized to ensure the absence of 
essential nutrients failed to generate biomass. (D) Phenylalanine, an essential 
amino acid, was subsequently corrected in the model to reflect experimental 
observations. (E) The model cytosolic ATP yield for different substrates plotted 
against the theoretical ATP yield as reported in Coles, Rutherford, and Moughan 
(2013). 
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Figure S2 Recon 2.1A produces ATP through the canonical reactions in 
central carbon metabolism under aerobic and anaerobic conditions. 
Cytosolic ATP consumption was maximized in aerobic (A) or anaerobic (B) 
conditions. 
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Figure S3 Nova Analyzer measurements and model predictions. Nova 
Analyzer measurements of the concentrations of glucose, glutamine, glutamate, 
ammonia, lactate, sodium and potassium (A-G) over time (in hours). These 
measurements, after normalizing to protein, are used to calculate the associated 
fluxes from the 48 hour mark. The model predicted no utilization of glutamate (H), 
sodium (I), potassium (J), or lactate (K). Measurement of these fluxes via the 
Nova Analyzer showed no statistically significant differences in glutamate (L) or 
lactate (O) and significantly higher uptakes of sodium (F) and potassium (G) in 
brown adipocytes compared to white adipocytes (p < 0.05). Error bars indicate 
s.e.m. 
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Figure S4 Predicted vs measured fluxes in brown and white adipocytes. 
The predicted fluxes for glucose, glutamine, palmitate, and ammonia (Figures 
2D-K) match the pattern of experimentally measured fluxes, although the 
predicted magnitudes were largely overestimated. 
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Figure S5 Relating flux predictions to gene expression differences in brown 
and white adipocytes. Plot of the concordance between flux prediction and 
gene expression for each subsystem in the model. For metabolic reactions in the 
model that had an associated gene-protein reaction (GPR) rule, the log2 fold 
change of the magnitude of the predicted fluxes was compared against the log2 
fold change in gene expression in brown compared to white adipose tissue. The 
numbers next to the bars indicate the fraction of concordant reactions (red) 
compared to the total number of reactions with GPRs (blue). 
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Tables 
Table 2 Estimated upper bounds of exchange fluxes based on media 
formulation 
Reaction 
name Description LB UB 
Corres-
ponding 
Metabolite 
Media 
concen-
tration [mM] 
Theoretical 
max flux 
[mmol/gDw/hr] 
Essen
-tial? 
EX_arg_L(e) L-Arginine exchange -1 1000 
L-Arginine-
HCl 0.398 0.074426 n 
EX_ca2(e) Calcium exchange -1 1000 
Calcium 
Chloride 
(CaCl2) 
(anhyd.) 
1.8 0.3366 y 
EX_cl(e) 
exchange 
reaction for 
Chloride 
-1000 0 
Sodium 
Chloride 
(NaCl), 
CaCl2, KCl 
110.34 20.63358 y 
EX_co2(e) CO2 exchange -100 1000 atmosphere 0 0 n 
EX_fe3(e) Fe3+ exchange -1 1000 
Ferric Nitrate 
(Fe(NO3)3-
9H2O) 
0.000248 4.64E-05 y 
EX_fol(e) 
exchange 
reaction for 
Folate 
-1000 0 Folic Acid 0.00906 0.001694 y 
EX_chol(e) 
exchange 
reaction for 
Choline 
-1000 0 Choline Chloride 0.0285 0.00533 y 
EX_glc(e) D-Glucose exchange -1 1000 D-Glucose 25 4.675 n 
EX_gln_L(e) 
exchange 
reaction for L-
glutamine 
-1 1000 L-Glutamine 4 0.748 n 
EX_gly(e) 
exchange 
reaction for 
Glycine 
-1000 0 Glycine 0.399 0.074613 n 
EX_h(e) 
exchange 
reaction for 
proton 
-100 1000 H2O 1000 1000 n 
EX_h2o(e) H2O exchange -100 1000 H2O 1000 1000 y 
EX_his_L(e) 
exchange 
reaction for L-
histidine 
-1000 0 L-Histidine HCl-H2O 0.2 0.0374 y 
EX_inost(e) myo-Inositol exchange -1 1000 i-Inositol 0.04 0.00748 n 
EX_k(e) K+ exchange -1 1000 KCl 5.3 0.9911 y 
EX_Lcystin(e
) 
L-Cystine 
exchange -1 1000 
L-Cystine 
2HCl 0.399 0.074613 n 
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EX_leu_L(e) L-Leucine exchange -1 1000 L-Leucine 0.802 0.149974 y 
EX_lys_L(e) L-Lysine exchange -1 1000 L-Lysine-HCl 0.798 0.149226 y 
EX_na1(e) 
exchange 
reaction for 
Sodium 
-1000 0 NaCl 110.34 20.63358 y 
EX_o2(e) 
exchange 
reaction for 
oxugen 
-1000 0 O2 1000 187 y 
EX_oh1(e) 
exchange 
reaction for 
hydroxide ion 
-1000 1000 H2O 1000 187 n 
EX_phe_L(e) 
exchange 
reaction for L-
phenylalanine 
-1000 0 
L-
Phenylalanin
e 
0.4 0.0748 y 
EX_pi(e) Phosphate exchange -100 1000 
Sodium 
Phosphate 
(NaH2PO4-
H2O) 
0.906 0.169422 n 
EX_pnto_R(e
) 
(R)-
Pantothenate 
exchange 
-100 1000 D-Ca pantothenate 0.0083 0.001552 n 
EX_pydx(e) 
exchange 
reaction for 
Pyridoxal 
-1000 0 Pyridoxal HCl 0.0196 0.003665 y 
EX_ribflv(e) 
exchange 
reaction for 
Riboflavin 
-1000 0 Riboflavin 0.00106 0.000198 y 
EX_so4(e) Sulfate exchange -100 1000 
Magnesium 
Sulfate 
(MgSO4) 
0.813 0.152031 n 
EX_thr_L(e) L-Threonine exchange -1 1000 L-Threonine 0.078 0.014586 y 
EX_trp_L(e) L-Tryptophan exchange -1 1000 L-Tryptophan 0.078 0.014586 y 
EX_tyr_L(e) L-Tyrosine exchange -1 1000 
L-Tyrosine 
2Na 2H20 0.398 0.074426 n 
EX_val_L(e) L-Valine exchange -1 1000 L-Valine 0.803 0.150161 y 
EX_ncam(e) Nicotinamide exchange -1 1000 Niacinamide 0.0328 0.006134 y 
EX_ser_L(e) 
exchange 
reaction for L-
serine 
-1 1000 L-Serine 0.4 0.0748 n 
EX_ile_L(e) L-Isoleucine exchange -1 1000 L-Isoleucine 0.802 0.149974 y 
EX_met_L(e) L-Methionine exchange -1 1000 L-Methionine 0.201 0.037587 y 
EX_thm(e) 
exchange 
reaction for 
Thiamin 
-1000 0 Thiamine HCl 0.0118 0.002207 y 
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Table 3 Classes of lipid species and their coefficients 
 
bat_comp sat_comp gat_comp metabolites 
CER 8.93E-05 9.39E-05 8.77E-05 crm_hs[c] 
DAG 0.000178 0.000248 0.000247 dag_hs[c] 
FFA 0.004348 0.002761 0.002984 ffa_hs[c] 
PC 0.005344 0.002004 0.001428 pchol_hs[c] 
PE 0.011158 0.001548 0.000781 pe_hs[c] 
PG 0.000347 6.64E-05 2.80E-05 pglyc_hs[c] 
PI 0.001013 0.000255 0.000155 pail_hs[c] 
PS 0.000614 0.000587 0.000368 ps_hs[c] 
SM 0.00031 0.000249 0.000194 sphmyln_hs[c] 
TAG 0.073581 0.14217 0.181437 tag_hs[c] 
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Table 4 Non-overlapping fluxes revealed by flux variability analysis 
react_ids BAT lb BAT ub WAT lb WAT ub name subsystem 
3DSPHR 0.000392 0.000408 3.86E-05 4.01E-05 3-Dehydrosphinganine reductase Sphingolipid metabolism 
AACOAT 0.277712 0.277712 0.109859 0.109859 Acetoacetyl-CoA:acetate CoA-transferase Propanoate metabolism 
ABTArm -0.37662 -0.37662 -0.17852 -0.0162 4-aminobutyrate transaminase, reversible (mitochondrial) Glutamate metabolism 
ACACT1r -0.27771 -0.27771 -0.10986 -0.10986 acetyl-CoA C-acetyltransferase Tryptophan metabolism 
ACACT1rm 0.277712 0.277712 0.092986 0.109859 acetyl-CoA C-acetyltransferase, mitochondrial Tryptophan metabolism 
ACCOAC 0.714117 0.714117 0.282496 0.282496 acetyl-CoA carboxylase Fatty acid oxidation 
AHC 0.001328 0.001328 0 2.91E-09 adenosylhomocysteinase Methionine and cysteine metabolism 
CSNATp 0.277712 0.277712 0.109859 0.109859 carnitine O-acetyltransferase, reverse direction, peroxisomal Fatty acid oxidation 
DGULND 0 2.86E-10 0.000517 0.000517 dehydro-L-gulonate decarboxylase Pentose phosphate pathway 
ENO 1.063266 1.063266 0.36038 0.377254 enolase Glycolysis/gluconeogenesis 
FAS100COA 0.119019 0.119019 0.047083 0.047083 fatty acyl-CoA synthase (n-C10:0CoA) Fatty acid synthesis 
FAS120COA 0.119019 0.119019 0.047083 0.047083 fatty-acyl-CoA synthase (n-C12:0CoA) Fatty acid synthesis 
FAS140COA 0.119019 0.119019 0.047083 0.047083 fatty-acyl-CoA synthase (n-C14:0CoA) Fatty acid synthesis 
FAS80COA_L 0.119019 0.119019 0.047083 0.047083 fatty acyl-CoA synthase (n-C8:0CoA), lumped reaction Fatty acid synthesis 
FTCD 0.028827 0.028827 0 0.008437 formimidoyltransferase cyclodeaminase Folate metabolism 
GluForTx 0.028827 0.028827 0 0.008437 Glutamate formimidoyltransferase Histidine metabolism 
GULN3D 0 2.91E-10 0.000517 0.000517 L-gulonate 3-dehydrogenase Pentose phosphate pathway 
HIBDm 0.150161 0.150161 0 0.050022 3-hydroxyisobutyrate dehydrogenase, mitochondrial 
Valine, leucine, and 
isoleucine metabolism 
HISD 0.028827 0.028827 0 0.008437 histidase Histidine metabolism 
HMGCOASim 0.277712 0.277712 0.092986 0.109859 Hydroxymethylglutaryl CoA synthase (ir) Cholesterol metabolism 
HMGLx 0.277712 0.277712 0.109859 0.109859 hydroxymethylglutaryl-CoA lyase Cholesterol metabolism 
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INOSTO 0 2.89E-10 0.000517 0.000517 inositol oxygenase Inositol phosphate metabolism 
IZPN 0.028827 0.028827 0 0.008437 Imidazolonepropionase Histidine metabolism 
MDHm -0.1495 -0.1495 -0.06429 0.033192 malate dehydrogenase, mitochondrial Citric acid cycle 
METAT 0.001328 0.001328 0 2.93E-09 methionine adenosyltransferase Methionine and cysteine metabolism 
METS 0.001328 0.001328 0 2.93E-09 methionine synthase Methionine and cysteine metabolism 
MMMm 0.150161 0.150161 -5.86E-09 0.050022 methylmalonyl-CoA mutase Valine, leucine, and isoleucine metabolism 
PCm 0.149504 0.149504 0 0.064286 pyruvate carboxylase Pyruvate metabolism 
PGM -1.06327 -1.06327 -0.37725 -0.36038 phosphoglycerate mutase Glycolysis/gluconeogenesis 
SERPT 0.000392 0.000408 3.86E-05 4.01E-05 serine C-palmitoyltransferase Sphingolipid metabolism 
SUCD1m -0.1495 -0.1495 -0.06429 5.85E-09 succinate dehydrogenase Citric acid cycle 
SUCOAS1m -0.22712 -0.22712 -0.11423 -0.0162 Succinate--CoA ligase (GDP-forming) Citric acid cycle 
TKT1 -7.08E-11 3.21E-10 0.000172 0.000172 transketolase Pentose phosphate pathway 
TKT2 -5.42E-11 3.21E-10 0.000172 0.000172 transketolase Pentose phosphate pathway 
URCN 0.028827 0.028827 0 0.008437 URCN Histidine metabolism 
XYLK 0 2.88E-10 0.000517 0.000517 xylulokinase Pentose phosphate pathway 
XYLTD_Dr 0 2.87E-10 0.000517 0.000517 xylitol dehydrogenase (D-xyulose-forming) Pentose phosphate pathway 
r0480 -3.75E-10 3.80E-10 -0.00018 -0.00018 
S-Adenosyl-L-methionine:ethanolamine-
phosphate N-methyltransferase 
Glycerophospholipid metabolism 
EC:2.1.1.103 
Glycerophospholipid 
metabolism 
r0788 -3.77E-10 3.54E-10 -0.00018 -0.00018 
S-Adenosyl-L-
methionine:methylethanolamine 
phosphate N-methyltransferase 
Glycerophospholipid metabolism 
EC:2.1.1.103 
Sphingolipid metabolism 
r0789 -3.92E-10 3.54E-10 -0.00018 -0.00018 
S-Adenosyl-L-
methionine:phosphodimethylethanolamin
e N-methyltransferase 
Sphingolipid metabolism 
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Glycerophospholipid metabolism 
EC:2.1.1.103 
CDIPTr_pmt_pmt -0.00035 -0.00035 -7.76E-06 -7.74E-06 
phosphatidylinositol synthase (Homo 
sapiens) 
Glycerophospholipid 
metabolism 
LCAT1e_lnlc_lnlc 0 -1.02E-10 0 2.93E-09 Lecithin-cholesterol acyltransferase Fatty acid oxidation 
PGPP_hs_pmt_pm
t 0.000354 0.000354 0 7.87E-06 
Phosphatidylglycerol phosphate 
phosphatase (homo sapiens) 
Glycerophospholipid 
metabolism 
PGPPT_pmt_pmt 0.000354 0.000354 0 7.76E-06 phosphatidyl-CMP: glycerophosphate phosphatidyltransferase 
Glycerophospholipid 
metabolism 
RE3273C_pmt_pm
t -0.00139 -0.00139 -3.77E-05 
-3.76E-
05 RE3273 
Phosphatidylinositol 
phosphate metabolism 
4ABUTtm -0.37662 -0.37662 -0.17852 -0.0162 4-aminobutanoate mitochondrial transport via diffusion Transport, mitochondrial 
ACACtx -0.27771 -0.27771 -0.10986 -0.10986 acetoacetate intracellular transport unknown mechanism Transport, peroxisomal 
AHCYStr -0.00133 -0.00133 -1.76E-08 0 S-Adenosyl-L-homocysteine intracellular diffusion 
Transport, endoplasmic 
reticular 
AMETr 0.001328 0.001328 0 1.75E-08 S-Adenosyl-L-methionine intracellular diffusion 
Transport, endoplasmic 
reticular 
ATPS4m 0.041555 0.041555 0.004974 0.004974 ATP synthase (four protons for one ATP) 
CO2tm -1.1661 -1.1661 -0.43247 -0.36627 CO2 transport (diffusion), mitochondrial Transport, mitochondrial 
CYOR_u10m 0.030326 0.030326 0.002609 0.002609 ubiquinol-6 cytochrome c reductase, Complex III Oxidative phosphorylation 
GLNtm 0.044922 0.044922 0 0.016408 L-glutamine transport via electroneutral transporter Transport, mitochondrial 
GLUt2m 0.135901 0.135901 0.018899 0.083918 L-glutamate reversible transport via proton symport, mitochondrial Transport, mitochondrial 
HMGCOAtm -0.27771 -0.27771 -0.10986 -0.10986 Hydroxymethylglutaryl-CoA reversible mitochondrial transport Transport, mitochondrial 
HMGCOAtx 0.277712 0.277712 0.109859 0.109859 Hydroxymethylglutaryl-CoA reversible peroxisomal transport Transport, peroxisomal 
NADH2_u10m 0.029669 0.029669 0 5.86E-09 NADH dehydrogenase, mitochondrial Oxidative phosphorylation 
O2Stm -0.0003 -0.0003 -2.61E-05 0 superoxide anion transport via diffusion (mitochondria) Transport, mitochondrial 
O2t 0.01486 0.015011 0.001796 0.001809 o2 transport (diffusion) Transport, extracellular 
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O2tm 0.015163 0.015163 0.001305 0.001305 O2 transport (diffusion) Transport, mitochondrial 
r0941 0.149504 0.149504 0 0.08116 Free diffusion Transport, mitochondrial 
CYOOm3 0.015163 0.015163 0 0.001305 cytochrome c oxidase, mitochondrial Complex IV Oxidative phosphorylation 
pail_hs_pmt_pmt_ 
isa_pail_hs_c 0.001034 0.001034 0 2.98E-05 isa pail hs 
pchol_hs_pmt_pmt 
_isa_pchol_hs_c 0.005456 0.005456 0.000234 0.000234 isa pchol hs 
pe_hs_pmt_pmt_ 
isa_pe_hs_c 0.011391 0.011391 0 0.000181 isa pe hs 
 
pglyc_hs_pmt_pmt 
_isa_pglyc_hs_c 0.000354 0.000354 0 7.75E-06 isa pglyc hs 
ps_hs_pmt_pmt_ 
isa_ps_hs_c 0.000627 0.000627 0 6.86E-05 isa ps hs 
 
sphmyln_hs_pmt_ 
isa_sphmyln_hs_c 0.000317 0.000317 0 2.91E-05 isa sphmyln hs 
EX_co2(e)ex 0.760089 0.760089 0.319221 0.358623 CO2 exchange Exchange/demand reaction 
EX_glc(e)in 0.5224 0.5224 0.169537 0.169537 D-Glucose exchange Exchange/demand reaction 
EX_gln_L(e)in 0.044922 0.044922 0.016408 0.016408 exchange reaction for L-glutamine Exchange/demand reaction 
EX_glu_L(e)ex 0.000762 0.000762 0.000887 0.000887 L-Glutamate exchange Exchange/demand reaction 
EX_gly(e)ex 0 1.60E-09 0.039857 0.156925 exchange reaction for Glycine Exchange/demand reaction 
EX_h(e)ex 0.002876 0.002876 0.000356 0.000356 exchange reaction for proton Exchange/demand reaction 
EX_hco3(e)ex 0.256916 0.265488 0 0.120671 Bicarbonate exchange Exchange/demand reaction 
EX_hdca(e)in 0.149689 0.149689 0.004269 0.004269 Hexadecanoate (n-C16:0) exchange Exchange/demand reaction 
EX_inost(e)in 0.001034 0.001034 0.000547 0.000547 myo-Inositol exchange Exchange/demand reaction 
EX_lac_L(e)in 0.00521 0.00521 0 0 L-Lactate exchange Exchange/demand reaction 
EX_lac_L(e)ex 0 0 0.017137 0.017137 L-Lactate exchange Exchange/demand reaction 
EX_nh4(e)ex 0.004083 0.004083 0.014563 0.014563 Ammonia exchange Exchange/demand reaction 
EX_o2(e)in 0.01486 0.01486 0.001796 0.001796 exchange reaction for oxugen Exchange/demand reaction 
DM_atp_m_ 0.011331 0.011331 0.001384 0.001384 ATP Demand NA 
Generic_pmt 0.004439 0.004439 0.000323 0.000323 Generic Palmitate NA 
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lipid_reaction_white 0 6.64E-11 0.116874 0.116874 Lipid Reaction White NA 
lipid_reaction_brown 1.020947 1.020947 0 1.38E-09 Lipid Reaction Brown NA 
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Table 5 Documentation of reactions changes from Recon 2.1x to Recon 
2.1A 
Reactions 
affected 
Observation Change Comments 
r0081, r0122, 
r0153, r0165, 
r0173, r0202, 
r0280, r0354, 
r0355, r0413, 
r0509 
Several of the reactions involved 
in the TCA are non-standard (by 
non-standard I mean not the 
classical textbook TCA cycle). 
They're not wrong per se, but 
could lead to some confusing 
results since they can support 
flux. 
Change 
bounds of 
these 
reactions to 
lb = ub = 0 
Shut off these reactions, 
forcing the modeling to use 
the alternative, canonical 
TCA cycle reactions. 
r2520, r0885 When maximizing cytosolic ATP 
consumption, 5/7 of the ATP 
transport from the mitochondria 
was due to the antiport of ATP 
and glutathione (reaction 
GTHRDt). The gradient would 
then be re-established by two 
other transport reactions involving 
antiport of gluthione and alpha-
ketoglutarate (reactions r2520 
and r0885), which results in 
erratic TCA cycle behavior.  
Change 
bounds of 
these 
reactions to 
lb = ub = 0 
By shutting off these two 
reactions (r2520 and r0885), 
the maximum ATP 
consumptions drops from 
~72 mmo/gDW/hr to ~27 
mmol/gDW/hr. 
ICDHyrm In the TCA cycle, the step from 
isocitrate to alpha-ketogluturate 
can by catalyzed by two different 
reactions: ICDHxm and ICDHyrm. 
The only difference between the 
two reactions is whether NAD 
(ICDHxm) or NADP (ICDHyrm) is 
used as the cofactor. In the TCA 
cycle, the associated reaction is 
believed to be ICDHxm, yet the 
model chooses the alternative 
ICDHyrm. 
Change 
bounds of the 
reaction to lb 
= ub = 0 
I couldn't think of a fix other 
than shutting off ICDHyrm. 
Doing so ensures the flux 
goes through ICDHxm: the 
canonical TCA cycle 
enzyme. 
SUCOASm Much like isocitrate 
dehydrogenase, there are two 
reactions that the model can use 
for succiate-coa ligase: 
SUCOAS1m (GDP-forming) and 
SUCOASm (ADP-forming). Unlike 
isocitrate dehydrogenase, 
however, both of these reactions 
are associated with the TCA 
cycle. In fact, there appears to be 
tissue-specific preferences for 
these enzymes (see PMCID: 
15234968).  
Change 
bounds of the 
reaction to lb 
= ub = 0 
In textbook biochemistry, the 
canonical reaction is thought 
to be SUCOAS1M (GDP-
forming). Thus, I'll shutoff 
SUCOASm.  
  
61 
FUM Fumurate dehydrogenase is 
found in at least two 
compartments: the mitochondria 
(FUMm) and the cytosol (FUM). 
By default, the model would use 
FUM since a related transporter 
reaction, FUMt, would antiport 
fumurate for monophosphate. 
Change 
bounds of the 
reaction to lb 
= ub = 0 
The only literature I could 
find was that the 
fumurate/phosphate 
transporter is SLC25A10. It's 
primarily expressed in the 
liver by several orders of 
magnitude. Thus, I'll shutoff 
the transport reaction since 
it's likely not relevant in 
adipocytes. 
DNPt1m, 
DNPt2m, 
DNPt3m, 
DNPt4m, 
DNPt5m, 
DNPt6m, 
DNPt7m, 
DNPt8m, 
DNPt9m, 
DNPt10m, 
DNPt11m, 
DNPt12m, 
DNPt13m, 
DNPt14m, 
DNPt15m, 
DNPt16m, 
DNPt17m, 
DNPt18m, 
DNPt19m, 
DNPt20m, 
DNPt21m, 
DNPt22m, 
DNPt23m, 
DNPt24m, 
DNPt25m, 
DNPt26m, 
DNPt27m, 
DNPt28m, 
DNPt29m, 
DNPt30m, 
DNPt31m, 
DNPt32m, 
DNPt33m, 
DNPt34m, 
DNPt35m, 
DNPt36m, 
DNPt37m, 
DNPt38m, 
DNPt39m, 
DNPt40m, 
DNPt41m, 
DNPt42m, 
DNPt43m, 
Most mitochondrial ATP is 
supposed to be exported via the 
ATP-ADP antiporter (ATPtm). 
However, the model prefers to 
use SLC25A19, which is (possibly 
was) believed to be a 
deoxynucleotide transporter in the 
mitochondria (hence it's 
annotation in the ATP-dADP 
antiporter, reaction DNDPt13m). 
However, looking at various 
databases and a review paper 
that came out in 2008 (see 
PMCID 18280798), it appears 
that SLC25A19 is in fact a 
thiamine pyrophosphate 
transporter. Thus, at the very 
least, the gene assignment is 
incorrect. 
Change 
bounds of 
these 
reactions to 
lb = ub = 0 
 The gene assignment is 
unchanged and remains 
incorrect independent of 
whether or not to leave 
these reactions on. In fact, 
there are 63 reactions 
involved in dNDP 
mitochondrial transport in 
the model that are 
incorrectly assigned to 
SLC25A19 (DNDPt1m - 
DNDPt63m). Biologically 
speaking, these reactions 
are necessary and should be 
on to allow for mitochondrial 
genome replication. 
Modeling speaking, since 
the biomass reaction does 
not include mitochondrial 
division, we can shut them 
off without producing 
infeasible constraints. By 
setting these reactions to 0, 
ATPtm now has a non-zero 
positive flux as desired. 
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DNPt44m, 
DNPt45m, 
DNPt46m, 
DNPt47m, 
DNPt48m, 
DNPt49m, 
DNPt50m, 
DNPt51m, 
DNPt52m, 
DNPt53m, 
DNPt54m, 
DNPt55m, 
DNPt56m, 
DNPt57m, 
DNPt58m, 
DNPt59m, 
DNPt60m, 
DNPt61m, 
DNPt62m, 
DNPt63m 
r1453 The model could create 1000 
ATP in the absence of glucose 
but in the presence of oxygen. 
Removing oxygen would create 0 
ATP, meaning that something in 
the electron transport chain was 
cheating. 
Change 
bounds of the 
reaction to lb 
= ub = 0 
One culprit was reaction 
r1453: a reaction that 
produced proline and q10h2 
by consuming hydrogen, 
q10, and 1pyr5c. 
Interestingly, this reaction 
was deleted in Recon 2.2 
and unassigned in Recon 
2.1x. It's likely that this 
reaction is incorrect, thus 
blocking it seems the most 
appropriate choice. Blocking 
it reduces ATP consumption 
from 1000 down to 483 
mmol/gDw/hr, suggesting 
that the model is still 
cheating. 
BAAT3x The model was still creating over 
483 mmol/gDw/hr with literally no 
glucose. After an exhaustive 
search, the error is within bile acid 
synthesis. One of the bile acid 
synthesis reactions has an 
unbalanced carbon reaction, thus 
creating carbon in the model. 
Change 
bounds of the 
reaction to lb 
= ub = 0 
I blocked reaction BAAT3x, 
which finally prevented 
significant ATP production in 
the absence of glucose. 
However, now the problem is 
that the model produces ~26 
mmol/gDw/hr. Textbooks 
place the number at around 
30-32. 
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Pltm The model would produce ~26 
mmol/gDw/hr, which was 6 
mmol/gDw/hr below the 
theoretical yield. The resultant 
fluxes suggested the problem was 
with phosphate transport, since 
the current model iteration would 
use phophate-succinate antiport 
to shuttle phosphate into the 
mitochondrial, which didn't make 
sense biologically. 
Change 
bounds of the 
reaction to lb 
= -1000, ub = 
1000 
The fix is to unblock the 
canonical mitochondrial 
phosphate transport: PIt2m. 
Doing so results in the 
model producing ~32 
mmol/gDw/hr, which is the 
theoretical yield of glucose 
oxidation. Note that it's 
unclear why the canonical 
phosphate transport reaction 
was blocked by default. 
CYOOm3 The model complex IV reaction 
produces superoxide (0.02 o2s 
per 1.98 h2O produced), thus 
producing 32.06 ATP per glucose 
instead of 32 since the model 
converts the superoxide into more 
oxygen through a reaction that 
also produces more carbon.  
Leave 
unchanged 
I haven't changed this since 
it's not, strictly speaking, a 
problem. In the model's 
current iteration, the 
remaining peculiarity is the 
overestimation of the 
ATP:substrate ratio that 
increases the higher the 
expected ATP yield is. In 
any case, I believe this may 
be enough given that our 
goal is to compare relative 
fluxes rather than calculate 
absolute fluxes 
RE0344C, 
RE0344X 
Maximizing triglyceride 
biosynthesis revealed a futile 
cycle that allowed the generation 
of near infinite triglycerides 
through stearate. 
Change 
bounds of 
these 
reactions to 
lb = 0, ub = 
1000 
The reactions RE0344C and 
RE0344X should be 
irreversible instead of 
reversible.  
PALFATPtc, 
RTOTAL2FAT
Pc_pmt , 
RTOTALFATP
c_pmt , 
RTOTAL3FAT
Pc_pmt 
The model would use 4 reactions 
for palmitate uptake (extracellular 
to cytoplasmic) that are active 
transport: PALFATPtc, 
RTOTAL2FATPc_pmt, 
RTOTALFATPc_pmt, 
RTOTAL3FATPc_pmt. These 
reactions normally occur in 
enterocytes and probably not in 
adipocytes. Interestingly, using 
these active transporters would 
not impact the final amount of 
ATP generated compared to 
passive lipid diffusion.  
Change 
bounds of 
these 
reactions to 
lb = ub = 0 
Simply turn off these 
reactions so that palmitate 
uptake is through passive 
diffusion. 
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Table 6 Comparison of lipid objective composition of white adipocyte lipid 
reactions from Recon 2.1A and iAdipocytes1850 
Metabolite Class Recon2.1
A 
iAdipocyt
e 
Recon2.1A 
metabolite 
iAdipocyte1850 
metabolite 
Ceramides 0.000626 0 crm_hs[c] - 
Diglycerides 0.001654 0.19 dag_hs[c] 1,2-diacylglycerol-LD-
TAG-pool[c] 
Free Fatty Acids 0.018406 0 ffa_hs[c] - 
Phosphotidylcholines 0.01336 0.0092 pchol_hs[c] PC-LD 
Phosphotidylethanolamin
es 
0.010322 0.0034 pe_hs[c] PE-LD 
Phosphotidylglycerols 0.000442 0 pglyc_hs[c] - 
Phosphotidylinositols 0.001702 0.0016 pail_hs[c] PI 
Phosphotidylserines 0.003912 0.0002 ps_hs[c] PS-LD 
Sphingomyelins 0.001659 0.0004 sphmyln_hs[
c] 
SM 
Triglycerides 0.947916 0.44 tag_hs[c] TAG-LD 
Cholesterol 0 0.005 - cholesterol[c] 
Cholesterol Esters  0 0.34 - cholesterol-ester 
pool[c] 
Glycerides 0 0.005 - fatty acid-LD-TG1 
lyso-Phosphotidylcholines 0 0.0006 - 2-lysolecithin pool[c] 
Plasmenylethanolamine 0 0.0008 - O-1-alk-1-enyl-2-acyl-
sn-glycero-3-
phosphoethanolamine[
c] 
Phosphotidylethanolamin
es 
0 0.0014 - 1-acyl-PE pool[c] 
lyso-Phosphotidylcholines 0 0.0024 - 1-radyl-2-acyl-sn-
glycero-3-
phosphocholine[c] 
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Table 7 Input fluxes and the corresponding reactions  
Measured Flux Equation Associated Reaction 
Basal 
Respiration 
!"#$%&%'  O2(e) ⇌ O2(c) 
Mitochondrial 
Respiration 
!"#$%&%' 	 − !"#+,-./,/. O2(c) ⇌ O2(m) 
ATP Production 
(Oxidative) 
4.6 ⋅ (!"#$%&%' 	 − !"#,'56,7895/) ADP(m) + 4H(c) + P(m)  
ATP(m) + H2O(m) + 3 H(m) 
Proton Leak 4.6 ⋅ (!"#,'56,7895/	 − !"#+,-./,/.) ATP(m) → ADP(m) + P(m) 
Maximal 
Respiratory 
Capacity 
!"#;<<=	 − !"#+,-./,/. O2(c) ⇌ O2(m) 
Extracellular 
Acidification 
>>#$%&%'  H(c) → H(e) 
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Chapter 2: Membrane Metallo-Endopeptidase (Neprilysin) Regulates 
Inflammatory Response and Insulin Signaling in White Preadipocytes 
Abstract 
Accumulation of subcutaneous white adipose tissue (WAT) is associated with 
increased insulin sensitivity, low levels of inflammation and a generally 
metabolically-healthy state, whereas accumulation of visceral adipose tissue is 
associated with insulin resistance, adipose tissue inflammation and metabolic 
syndrome. Membrane Metallo-Endopeptidase (MME/Neprislyin) is an 
extracellular, membrane-bound protease enriched in subcutaneous WAT that 
can target degradation of a variety of peptides, including insulin, IL6, and β-
amyloids. Here, we show that MME in white preadipocytes is differently 
expressed in subcutaneous vs visceral WAT, and favors insulin signaling and a 
low inflammatory response. Thus, knockdown of MME in preadipocytes 
increases the inflammatory response to substance P and amyloidβ aggregates. 
This is associated with increased basal insulin signaling and decreased insulin-
stimulated signaling. Moreover, MME differentially regulates the internalization 
and turnover of the α/β subunits of the insulin receptor. Thus, MME is a novel 
regulator of the insulin receptor in adipose tissue and may serve as a therapeutic 
target to increase insulin sensitivity and decrease inflammatory susceptibility. 
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Graphical Abstract 
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Introduction 
Adipose is complex tissue which has an important role in energy homeostasis, 
endocrine function, and the regulation of immune response. It has a high degree 
of plasticity and is capable of expanding, contracting and remodeling to meet a 
wide range of metabolic challenges (Hyvönen and Spalding, 2014). Adipose 
tissue is primarily composed of adipocytes and adipocyte progenitors, but also 
contains perivascular cells, endothelial cells, and a myriad of immune cells. 
Adipocytes are the main adipose constituent by mass and serve the primary role 
for energy storage and endocrine function. Preadipocytes represent a small 
mass of tissue, but can comprise as much as 50% of adipose tissue by cell 
number and are the primary source for new adipocytes (Tchkonia et al., 2013). 
These adipose progenitors have also been shown to have multi-lineage 
differentiation potential and thus serve as potential source for mesenchymal stem 
cells (Zuk et al., 2002). 
 
Adipose tissue can be divided into at least two metabolically-distinct types: brown 
adipose tissue (BAT) and white adipose tissue (WAT). BAT is primarily an energy 
expending tissue, whose human-relevance has recently become an active area 
of research (Cypess et al., 2013; Shinoda et al., 2015). White adipose tissue, in 
contrast, is primarily an energy storing tissue. White adipose tissue has been 
shown to have regional variation based on anatomical location in humans 
(Ibrahim, 2010; Tchoukalova et al., 2010). Some of the most striking differences 
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in WAT are observed between (abdominal) subcutaneous and visceral white 
adipose tissue. Accumulation of visceral adipose tissue, i.e. central obesity, has 
been associated with insulin resistance, metabolic syndrome, and diabetes 
mellitus (Kelley et al., 2000; Ibrahim, 2010; Tran and Kahn, 2010). By contrast, 
accumulation subcutaneous adipose tissue has been associated with 
metabolically beneficial characteristics, including increased insulin sensitivity and 
decreased inflammation (Kim et al., 2007; Tran and Kahn, 2010). White adipose 
tissue from other regions, such as gluteal adipose tissue, perirenal fat, and bone 
marrow adipose tissue, also have differences in properties, including differences 
in cytokine response and proliferation rates (Karastergiou et al., 2013; Cawthorn 
et al., 2014). This regional variation within white adipose tissue stresses the need 
to understand the underlying mechanisms accounting for differences in white 
adipose depots in order to develop targeted therapies for diabetes, lipodystrophy 
and related metabolic complications. 
 
Several molecular differences between visceral and subcutaneous adipose 
tissue have been described. One of the most demarcating differences between 
adipose depots is the signature of developmental genes, including Hox, Shox, 
and T-box genes (Gesta et al., 2006; Yamamoto et al., 2010). Lineage tracing 
studies have revealed key developmental signatures in adipocyte development, 
such as the Myf5 lineage marking brown adipocytes and a subset of white 
adipocytes across different fat depots (Sanchez-Gurmaches et al., 2012; 
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Sanchez-Gurmaches and Guertin, 2013). The mesodermal developmental gene 
TBX15 has also been shown to mark a subset of white adipocytes which have a 
higher glycolytic rate (Lee et al., 2017). Traditionally, surface markers have been 
used to establish region specificity and to distinguish adipocyte-lineage cells from 
other adipose-resident cells, although there is disagreement over the exact panel 
of surface marker expression in the adipocyte lineage (Cawthorn et al., 2012; 
Ussar et al., 2014). More extensive reviews on this topic are provided elsewhere 
(Gesta et al., 2007; Tchkonia et al., 2013; Schoettl et al., 2018). 
 
Membrane metallo-endopeptidase (MME/Neprilysin/CD10/CALLA) is a 
membrane-bound protein with a distinct extracellular protease domain. MME was 
first isolated from rabbit kidney and described as a thermolysin-like enzyme (Kerr 
and Kenny, 1974). Since then, MME has been shown to be well-conserved 
across different species from C. elegans to mammals (Bland et al., 2008). MME 
is a zinc metalloprotease and shares substrates and structural similarity with 
several related extracellular proteases, including Endothelin Converting Enzyme 
1 (ECE1), Phosphate-regulating neutral endopeptidase X-linked (PHEX), and 
Kell blood group antigen (KEL) (Johnson et al., 1999; Whyteside and Turner, 
2008; Webster et al., 2014). MME is also expressed in the brain, where the MME 
knockout mouse has been shown to have an increase in amyloidβ peptides, 
suggesting MME may play a role in protection from Alzheimer’s disease 
(Yasojima et al., 2001). The whole-body MME knockout (MMEKO) mouse was 
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created in 1995 and was described as a septic shock model because it showed 
hypersensitivity to treatment with different cytokines (Lu et al., 1995). 
 
In the context of metabolism, the MMEKO mouse develops age-related obesity. 
This is thought to be mediated through hyperphagia (Becker et al., 2010), 
although the exact mechanism is unclear. Interestingly, whole-body knockdown 
or overexpression of the Drosophila MME homolog NEP4 decreases larval food 
intake and decreases the levels of circulating insulin-like peptide DILP1 (Hallier 
et al., 2016). In humans, MME is also found in plasma and circulating levels of 
MME positively correlate with BMI and HOMA-IR (Standeven et al., 2011). 
Additionally, MME mutants have been associated with Charcot-Marie-Tooth 
disease (Higuchi et al., 2016), emphasizing that MME is expressed in a variety of 
tissue types, including adipose, brain and lymphatic tissue (Lu et al., 1995; 
Yasojima et al., 2001; Becker et al., 2010).  
 
MME has been shown to target a variety of small peptides including amyloidβ, 
insulin B-chain, and several neuropeptides (Sexton et al., 2012; Webster et al., 
2014). Additionally, the MME intracellular domain is known interact with PTEN, 
suggesting it potentially could modify signaling pathways active via the PI3K/Akt 
pathway (Siepmann et al., 2010; Maguer-Satta et al., 2011; Kim et al., 2017). 
Both adipocytes and preadipocytes express MME, and preadipocytes have been 
shown to secrete exosome-bound MME, which can be endocytosed by non-
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adipose cell types such as neuronal cells in vitro (Katsuda et al., 2013). 
In the present study, we sought to determine the cellular role of MME in 
distinguishing subcutaneous from visceral preadipocytes, and its role in insulin 
sensitivity and inflammatory response in adipose tissue. 
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Methods 
Human cell culture 
Primary cell cultures (4 abdominal subcutaneous, 4 omental, and 4 mesenteric) 
were obtained from the Kirkland lab (Tchkonia et al., 2007). Primary cells for 
subcutaneous, omental, and mesenteric preadipocytes were grown to 90% 
confluency in 10-cm plates. For primary cell cultures were maintained no more 
than 10 passages. Human neck-derived immortalized white preadipocyte cell 
lines were obtained from the Tseng lab and cultured as previously described 
(Xue et al., 2015; Kriszt et al., 2017). Cells were maintained in DMEM-H, 10% 
FBS, 1% Pen-Strep (100 U/mL), and 0.2% normocin (100 μg/mL). Cells were 
passaged at 90% confluency by a 1:5 dilution. 
 
RNA sequencing 
Total RNA was harvested from a 100% confluent 10-cm plate with 1 mL Trizol 
and stored at -80° C. Samples were thawed, homogenized with a 25-gauge 
needle, and 200 μL chloroform was added. The samples were vortexed (20 s), 
centrifuged (15,000 g, 30 min), and the aqueous phase was isolated for 
purification. The aqueous phase was combined with 1 volume of isopropanol, 
centrifuged (15,000 g, 60 min), and washed with 70% ethanol. The resulting RNA 
pellet was air dried for 1 hr and resuspended in 30 μL RNase-free water. RNA 
quality was assessed on an Agilent 2100 Bioanalyzer to ensure RIN values were 
greater than 8.0. 
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For library prep, we used the NEBNext Ultra Directional Library Prep Kit (New 
England Biolabs). Briefly, 500 ng of RNA in 50 μL water was combined with 15 
μL NEBNext Oligo d(T)25 magnetic beads (pre-washed twice with RNA binding 
buffer) and incubated at 65° C for 5 min. The beads were washed twice with 200 
μL wash buffer and eluted with 200 μL elution buffer. The binding-washing was 
repeated once more. The final elution was in 15 μL first strand synthesis buffer 
and incubated at 94° C for 15 min. Then 10 μL of the supernatant was used for 
cDNA synthesis reaction, which was purified using Agencourt AMPure XP beads. 
End-repair was performed with NEBNext end repair reaction buffer and purified 
with AMPure XP beads. Library enrichment and multiplexing was performed 
using the NEBNext High-Fidelty PCR Master Mix (14 cycles of PCR) and 
NEBNext Multiplex Oligos.  
 
The cDNA libraries were multiplexed on the Illumina HiSeq 2000 and 2500. Raw 
50bp paired-end reads were aligned via the Spliced Transcripts to Alignment 
Reference (STAR 2.3.0e) (Dobin et al., 2013) to the human genome build hg19 
and annotation file gencode v19. The non-default and non-directory parameters 
for building the reference genome in STAR were: STAR --runMode 
genomeGenerate --sjdbOverhang 49 --runThreadN 8, and the parameters for 
alignment were STAR --readFilesCommand bzcat --outFilterMismatchNmax 6 --
outFilterIntronMotifs RemoveNoncanonicalUnannotated. Raw counts from the 
alignment files were extracted using HT-seq (v0.5.4) with the following 
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parameters: htseq-count -i gene_id -q -m union -s reverse. Exploratory and 
differential gene expression analyses were carried out in R (v3.03) and other 
packages including DESeq2 (Love et al., 2014), EBimage (Pau et al., 2010), and 
ggplot2 (Wickham). 
 
Murine inguinal and epidydimal cell culture and microarray 
Wild-type C57BL/6 male mice were maintained on chow diet. Mice aged 49-63 
days were sacrificed and the inguinal and epidydimal adipose depots were 
surgically extracted. The fat pads were minced, incubated with 5 mL digestion 
buffer (DMEM-H, 1%BSA, 1 mg/mL collagenase) and incubated on a shaking 
water bath for 30 min at 37° C. The solution was filtered through a 150-250 μm 
mesh-syringe, combined with 10 mL 1%-BSA DMEM-H and centrifuged (800 g, 5 
min, 4° C). The supernatant was removed, the pellet was washed with 10 mL 
FACS buffer (PBS, 2% Fetal Calf Serum) and centrifuged again (800 g, 5 min, 4° 
C). The pellet was resuspended in 1 mL erythrocyte lysis buffer (Ammonium-
Chloride-Potassium lysis buffer) and incubated on ice for 5 min. FACS buffer was 
added to bring the volume to 10 mL and centrifuged (800 g, 5 min, 4° C). The 
supernatant was aspirated, the pellet was resuspended in 300 μL Blocking buffer 
(PBS, 2% Fetal Calf Serum, 1:150 Fc Block (BD Biosciences)) and centrifuged 
(800 g, 5 min, 4° C). The pellet was resuspended in 100 μL of the antibody mix 
(CD45-, TER119-, CD31-, CD34+, Sca1+) and incubated for 15 min on ice. 
Blocking buffer was added to bring the volume to 250 μL and centrifuged (800 g, 
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5 min, 4° C). The pellet was resuspended in 200 μL FACS buffer, submitted to 
FACS, and plated onto 6-well plates. Total RNA was harvested by Trizol and 
submitted to the Joslin Diabetes Center Genomics Core for microarray 
hybridization to generate gene expression profiles. 
 
Quantitative PCR 
RNA was extracted via the Qiagen RNAeasy mini kit (Qiagen). Complementary 
DNA synthesis was performed with 200 ng/sample of RNA via the High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems). Quantitative PCR was 
performed via the SYBR Green PCR Master Mix (Bio-Rad) on the CFX384 Real-
Time PCR Detection System according to the manufacturer’s protocol. For 
relative qPCR, expression was normalized to the reference gene HPRT1. For 
absolute qPCR, synthetic templates were created as a single gBlock (IDT) and 
used to calculate copy number. 
 
The sequences for primers or gBlock are as follows: HPRT1 (F:5’-
TGAAAAGGACCCCACGAAG, R:5’-AAGCAGATGGCCACAGAACTAG), MCP1 
(F:5’-CATAGCAGCCACCTTCATTCC, R:5’-
TCTGCACTGAGATCTTCCTATTGG), TNFα (F:5’-
TCAGAGGGCCTGTACCTCAT, R: 5’-GGAGGTTGACCTTGGTCTGG), IL6 (F:5’-
GGTACATCCTCGACGGCATCT, R:5’-GTGCCTCTTTGCTGCTTTCAC), MME 
exon 2 (F: 5’-GCTATTGATAGCAGAGGTGGAGA, 5’-
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GTTGCTACTGGCCACCCATA), MME exon 10 (F: 5’-
TGTGGCCAGATTGATTCGTCA, R:5’-TGGCAATTTCTTTTTCCAATTCCA), 
MME exon 20 (F:5’-GAGATGTGCAAGTGGCGAAG, R:5’-
GTGACCCCTCAGCAGATCC), MME exon 21 (F:5’-
TCTCGACAATACCCGTTGGC, R:5’-GAGTGGCAGAATAGGGCTGG) , and the 
synthetic template for absolute qPCR (5’-
GGGGTCTCGACAATACCCGTTGGCAAGGAGTCTGCCTCCATGCTGCAGTGT
TCGAGTGGATTGTAGGTGCAAGATGGAAAGGATTGTAGGTGCAAGCTGTCC
AGAGAAAAGAGTCCTTGTTCCAGCCCTATTCTGCCACTCTTTTTGAGATGTG
CAAGTGGCGAAGCTTGACCGAGAGCAGGCTGGAGCAGCCGCCCAACTCCT
GGCGCGGGATCTGCTGAGGGGTCACTTTTTTGTGGCCAGATTGATTCGTCA
GGAAGAAAGATTGCCCATCGATGAAAACCAGCTTGCTTTGGAAATGAATAAA
GTTATGGAATTGGAAAAAGAAATTGCCATTTTTGCTATTGATAGCAGAGGTG
GAGAACCTCTACTCAAACTGTTACCAGACATATATGGGTGGCCAGTAGCAA
CTTTTTTGAAAAGGACCCCACGAAGTGTTGGATATAAGCCAGACTTTGTTGG
ATTTGAAATTCCAGACAAGTTTGTTGTAGGATATGCCCTTGACTATAATGAAT
ACTTCAGGGATTTGAATCATGTTTGTGTCATTAGTGAAACTGGAAAAGCAAA
ATACAAAGCCTAAGATGAGAGTTCAAGTTGAGTTTGGAAACATCTGGAGTCC
TATTGACATCGCCAGTAAAATTATCAATGTTCTAGTTCTGTGGCCATCTGCTT
GGGG). 
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MME perturbations and insulin signaling 
Immortalized human neck derived white preadipocytes, generated as previously 
described (Xue et al., 2015), were transfected with MME or non-targeting control 
(GFP) siRNA using Lipofectamine 3000 (Thermo Fisher) for 24 or 48 hours. For 
the pharmacological inhibition of MME experiments, preadipocytes were 
incubated for 24 or 48 hours with the MME inhibitor omapatrilat (1 μM). For 
overexpression, the plasmids pCMV-GFP (Addgene #12337), pCMV-MME 
(Addgene #12338), or pCMV-MMEX (Addgene #12340) were transduced for 48 
hours with Lipofectamine 3000. The preadipocytes were then serum-starved 
overnight (24 hours) and stimulated with or without 100 nM insulin for 20 
minutes. Cell lysates were collected on ice with cell lysis buffer (1X RIPA, 0.1% 
SDS, 1X protease and phosphatase inhibitor cocktails (Bimake)). Lysates were 
centrifuged (10000 g, 10 min), and supernatants were used for immunoblotting. 
 
Immunoblotting 
Purified protein lysates were quantified with a bicinchoninic acid (BCA) assay 
(ThermoFisher). For SDS-PAGE, 20 μg/sample of prepared protein (cell lysate 
with 1X LDS sample buffer) were run on a 4-12% Bis-Tris polyacrylamide gel at 
120 V for 60 min in 1X running buffer (2.5 mM MOPS, 2.5 mM Tris base, 0.005% 
SDS, 50 μM EDTA, pH 7.7). Protein was transferred to PVDF membrane at 30 V 
for 960 minutes in 1X transfer buffer (1.25 mM Bicine, 1.25 mM Bis-Tris, 50 μM 
EDTA, pH 7.2). Membranes were blocked in Starting Block T20 (ThermoFisher). 
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Primary antibodies were used at a 1:2000 dilution (MME (human: Santa Cruz, 
mouse: Abcam), IRα (Santa Cruz), IRβ (Cell Signaling), pIR/pIGF1R (Cell 
Signaling), IRS1 (Millipore), pIRS1 (Cell Signaling), pan-AKT (Cell Signaling), 
pAKT (Cell Signaling), ERK1/2 (Cell Signaling), pERK1/2 (Cell Signaling), Actin 
(Santa Cruz), GAPDH (Santa Cruz). Secondary antibodies were used at a 
1:10000 dilution (anti-mouse (Bio-Rad) or anti-rabbit (Bio-Rad)). Signal was 
detected by Pico or Femto Chemiluminescent Substrate (ThermoFisher). 
 
MMEKO mice and GTT/ITT 
MMEKO mice, originally created on a C57BL/6 background, were kindly provided 
by Bao Lu (Lu et al., 1995) to create a colony at Joslin Diabetes Center. MMEKO 
mice were bred with WT C57BL/6 mice from Charles River Laboratories, and F2 
homozygous male KO mice were used for subsequent experiments. MMEKO 
and WT mice were maintained on chow diet (22% fat by weight). For glucose 
tolerance testing, 20-week-old mice were starved for 16 hours before 
intraperitoneal injection of 10 μg/gBW (micrograms per gram body weight) 
glucose. For insulin tolerance testing, the same cohort at 22-weeks old was 
starved for 4 hours and then injected intraperitoneally with 0.1 mU/gBW insulin. 
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Isolation of preadipocytes from MMEKO and WT mice 
MMEKO and WT mice aged 12-weeks were sacrificed with isoflurane. The 
inguinal and epididymal adipose tissue depots were surgically removed, minced, 
and placed in 500 μL digestion buffer (DMEM-H, 2% BSA, 1.5 mg/mL 
collagenase). The solutions were placed in a shaking water bath (37° C, 90 
cycles/min) until cells were dispersed, but for no more than 40 minutes. Then, 20 
mL growth media (DMEM-H, 10% FBS, 1% Penicillin-Streptomycin, 0.2% 
Normocin) was added, the suspension filtered through a 100-μm cell strainer and 
centrifuged (1500 rpm, 5 min). The supernatant was aspirated, the stromal 
vascular pellet containing preadipocytes was re-suspended in 2 mL growth 
media and plated into a single well of a 6-well plate.  
 
Insulin receptor internalization 
Immortalized human neck-derived white preadipocytes (Xue et al., 2015; Kriszt et 
al., 2017) were seeded at 50,000 cells/well in 6-well plates. Transient 
overexpression or knockdown MME was performed as described above. Cells 
were serum-starved overnight (24 hours) and then stimulated with 100 nM insulin 
for 0, 30 min, or 120 min. Cells were washed with ice-cold 1X PBS and incubated 
with Sulfo-NHS-Biotin (0.3 mg/mL in PBS) for 30 min at 4° C to label cell surface 
proteins. The biotinylation reaction was quenched with 4° C 100 mM glycine. 
Cells were washed with ice-cold 1X PBS and lysed in a buffer containing 1X 
RIPA, 0.1% SDS, 1X protease and phosphatase inhibitor cocktails (Bimake). 
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Lysates were centrifuged (10000 g, 10 min), and the supernatant was used for 
streptavidin pulldown. 
 
Purified protein lysates were quantified with a bicinchoninic acid (BCA) assay 
(ThermoFisher). For each sample, 100 μg of protein was combined with 10 μL of 
magnetic streptavidin beads and incubated on a rotating rack at 4° C overnight. 
The beads pellets were washed with 600 μL 1X RIPA, 600 μL 1X RIPA + 500 
mM NaCl, and 600 μL 1X RIPA in series. The bead pellets were eluted with 40 
μL 1X LDS buffer incubated at 96° C for 5 min. The immunoprecipitates and total 
protein were used for SDS-PAGE and western blot as described above. 
 
Subcellular fractionation 
Cell fractionation in immortalized human neck-derived white preadipocytes was 
performed using a subcellular fractionation kit (Thermo Fisher #78840). Briefly, 
MME overexpression in 6-well plates was performed as described above. Lysis 
buffers CEB, MEB, NEB, and PEB were prepared as described in the 
manufacturer’s protocol. Cells were scrapped as a single layer, centrifuged (5 
min, 500g), washed with ice-cold 1X PBS, and lysed with 200 μL/sample ice-cold 
CEB (incubated at 4° C for 10 min on a rotary shaker). Pellets were centrifuged 
(5 min, 500 g), supernatant collected (cytoplasmic fraction), and 200 μL/sample 
ice-cold MEB was added (vortexed for 5 s and incubated at 4° C for 10 min). 
Pellets were centrifuged (5 min, 3000 g), supernatant collected (membrane 
  
82 
fraction), and 100 μL/sample ice-cold NEB was added (vortexed for 15 s and 
incubated at 4° C for 30 min). Pellets were centrifuged (5 min, 5000 g), 
supernatant collected (soluble nuclear fraction), and 100 μL/sample ice-cold 
chromatin-NEB was added (vortexed for 15 s, incubated at 37° C for 5 min, and 
vortexed again for 15 s). Pellets were centrifuged (16000 g, 5 min), supernatant 
collected (chromatin fraction), and 100 μL/sample of ice-cold PEB was added 
(vortexed for 15 s and incubated at room temp for 10 min). Pellets were 
centrifuged (16000 g, 5 min), and the supernatant collected (cytoskeletal 
fraction). Isolates were stored at -80° C. 
 
Insulin receptor MME co-immunoprecipitation 
Immortalized murine brown IR/IGFR double-knockout preadipocytes (Boucher et 
al., 2010) were seeded at 50,000 cells/well in 6-well plates. Preadipocytes were 
then transiently transfected with FLAG-tagged insulin receptor (pCMV-IR-
3XFLAG), MME (pCSC-SP-PW-Nep, Addgene #12338), or a combination of the 
two for 48 hours before insulin signaling. For insulin signaling, cells were serum-
starved for 3 hours and incubated with or without insulin for 15 minutes and 
harvested with 1 mL/well co-ip lysis buffer (20 mM Hepes (pH 7.4), 150 mM 
NaCl, 50 mM KF, 50 mM β-glycerolphosphate, 2 mM EGTA (pH8.0), 1 mM 
Na3VO4, 1% Triton X-100, 10% glycerol, and 1× protease inhibitor cocktail 
(Calbiochem)). Lysates were centrifuged (10000 g, 10 min) and the supernatant 
was used for immunoprecipitation. 
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Anti-FLAG M2 magnetic beads were washed twice with co-ip lysis buffer prior to 
use. For each sample, 600 μg protein lysate was combined with 20 μL washed 
M2 magnetic beads and incubated overnight on a rotating rack at 4° C. The bead 
pellets were washed three times each with 1 mL co-ip lysis buffer, 1 mL co-ip 
lysis buffer + 500 mM NaCl, and 1 mL co-ip lysis buffer. The bead pellets were 
then eluted with 40 μL 1X LDS (Lithium Dodecyl Sulfate) running buffer 
incubated at 96° C for 5 min. The immunoprecipitates and total protein were used 
for SDS-PAGE and western blot as described above.  
 
MME inflammation assays 
Immortalized human neck-derived white preadipocytes were seeded at 50,000 
cells/well in 6-well plates and MME knockdown were performed as described 
above for 24-hours. For inflammatory response in primary stromal vascular cells, 
subcutaneous and omental preadipocytes were seeded at 30,000 cells/well in 
24-well plates. Cells were serum-starved for 24 hours and then treated with IL1β 
(5 ng/μL), Substance P (100 nM), Amyloidβ aggregates (20 μM), and/or 
Omapatrilat (1 μM) for 24 hours. Amyloidβ aggregates were generated by 
incubating Amyloidβ peptide (fragment 25-35; 40 μM) for 7 days at 37° C. Cell 
lysis and RNA extraction was performed with the Qiagen RNAeasy mini kit 
(Qiagen), and qPCR was performed as described above. 
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Human protein-protein interactome between MME and INSR 
The human protein-protein interaction network pulled from BioGRID (Biological 
General Repository for Interaction Datasets) was used to determine the shortest 
paths between insulin receptor (INSR) and MME. Briefly, the R package igraph 
was used to analyze the protein-protein interactome (PPI). The PPI (Biogrid-ALL-
3.4.145) was loaded and the shortest paths between INSR and MME were 
determined with Djikstra’s algorithm via the function all_shortest_paths. 
Normalized, pre-processed RNA-seq data from subcutaneous adipose tissue 
was taken from ENCODE (Lin et al., 2014). 
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Results 
Preadipocytes show depot-specific gene expression patterns 
RNA-seq was performed human preadipocytes from subcutaneous and two 
visceral depots: omental and mesenteric fat. These were compared to the two 
standard murine depots used to represent subcutaneous and visceral fat, namely 
the inguinal and epididymal, respectively. Principle component analysis of the 
data showed that the gene expression profiles cluster by depot of origin in both 
human (Figure 5A) and murine (Figure 5B) preadipocytes. Gene set enrichment 
analysis of differential gene expression between subcutaneous and visceral 
preadipocytes (represented by subcutaneous vs omental fat in humans and 
inguinal vs epididymal in the mouse) showed a set of 20 significant pathways 
which showed conserved differential expression across species (Figure 5C).  
 
The majority of these pathways were related to metabolism of different 
substrates and were lower in expression in rodent inguinal vs epididymal fat, as 
well as human subcutaneous vs omental fat (Figure 5C). These included 
pathways of branched-chained amino metabolism, short-chain fatty acids 
metabolism (e.g. butanoate metabolism), and pyrimidine metabolism. They also 
included several disease-defined pathways (e.g. Alzheimer’s disease and 
Huntington’s disease), which reflected differences in expression of genes in the 
mitochondrial electron transport chain. Interestingly, several pathways were 
annotated a being cardiac-related (e.g. dilated cardiomyopathy and viral 
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myocarditis); these represented differences in genes involved in calcium 
signaling and regulation of the extracellular matrix. Differences in cell surface 
markers (e.g. hematopoietic cell lineage) and in glycosphingolipid biosynthesis 
were up in subcutaneous preadipocytes of both mice and humans. The former 
has been previously described (MacKenzie et al., 2008; Li et al., 2011; Ong et 
al., 2014). 
 
Membrane metallo-endopeptidase marks subcutaneous preadipocytes but not 
visceral preadipocytes 
In order to narrow the genes contributing to these differences, we sought to 
determine the genes common across at least two pathways. A total of 10 genes 
were found in overlapping pathways and significantly different between the inter-
depot comparisons, although only 4 genes (F11R, MME, ITGB8, and ABAT) 
were in common across statistically significant pathways (Figure 6A). Of these 4 
genes, MME was the only gene significantly higher in subcutaneous 
preadipocytes compared to visceral preadipocytes in both human (Figure 6B) 
and mouse (Figure 6C), and was found in two significant pathways: Alzheimer’s 
disease and Hematopoietic cell lineage. 
 
The MME gene encodes a 750 amino acid (AA) protein product with three 
distinct domains: an N-terminal 28-AA intracellular domain, a 23-AA 
transmembrane domain, and a 699-AA extracellular domain ending at the C-
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terminus of the protein (Maguer-Satta et al., 2011) (see structure at bottom of 
Figure 7A). Previous research has reported MME has tissue-specific alternative 
splicing in the 5’-UTR for the same 750-AA protein isoform (D’Adamio et al., 
1989; Li et al., 1995). Additionally, the annotation of the human genome 
suggested a putative isoform with a shorter 80-AA protein having a truncated 
extracellular domain (MME isoform B, RefSeq NP_001341573.1) (Strausberg et 
al., 2002; Muzny et al., 2006). Several other truncated transcripts from the MME 
locus have bene reported, although not all have been shown to produce a protein 
product (Llorens-Cortes et al., 1990; Iijima et al., 1992).  
 
To determine whether subcutaneous or omental preadipocytes had preferential 
exon expression in the MME gene, we subjected our RNA seq data to differential 
exon usage (DEXSeq) (Anders et al., 2012; Ritchie et al., 2015). Differential exon 
splicing showed subcutaneous preadipocytes has less expression of exon 12 
(ENSE00000934033) compared to every other exon (exons 1-11 and exons 13-
23) within the MME gene (Figure 7A). Exon 12 codes for a 32 amino acid 
segment in the first catalytic domain (amino acid position 79-483). Interestingly, 
loss of exon 12 produces an in-frame deletion. Thus the translated product would 
be a 718 amino acid protein product with an intact catalytic domain. Absolute 
qPCR using synthetic standards confirmed the exon-specific regulation of MME 
between subcutaneous and omental preadipocytes (Figure 7B), although the 
significant exon was exon 14 (ENSE00000934033). These two exons are found 
  
88 
in the same extracellular N-terminal peptidase domain. These results suggest 
that the depot-specific regulation of these exons may influence the expression of 
truncated MME protein isoforms.  
 
MME regulates the inflammatory response of white preadipocytes  
The extracellular region of MME is known to function as a protease for a variety 
of substrates including several pro-inflammatory cytokines (Sexton et al., 2012; 
Webster et al., 2014). To determine whether reducing MME expression in 
subcutaneous preadipocytes would reduce the response to pro-inflammatory 
cytokines, we transiently knocked down MME in immortalized human neck (HN) 
white subcutaneous preadipocytes using RNAi. The expression of MME mRNA 
was reduced by 60% as assessed by qPCR (Figure 8A). This produced a 90% 
reduction of MME protein expression even at the lowest siRNA amount (30 pmol) 
as determined by Western blotting (Figure 8B). To determine if this affected 
cellular response to peptides that have been shown to be degraded by MME, we 
then exposed the cells to substance P or amyloidβ aggregates. Consistent with a 
role for MME in response to these stimuli, there was an increase in the ability of 
both substance P and amyloidβ aggregates to stimulate IL6 and MCP1 RNA 
expression (Figure 8C). Expression of TNF-α RNA expression showed similar 
trends to increase in expression in response to these inflammatory mediators, 
but did not reach statistical significance (Figure 8C).  
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Interestingly, exposure to IL1β, a pro-inflammatory cytokine postulated (but not 
proven) to be a target of MME (Van Der Velden and Hulsmann, 1999; Maguer-
Satta et al., 2011), did not have higher expression of MCP1 or IL6 in the MME 
knockdown. These results suggest that the MME-degradation targets substance 
P and amyloidβ may be involved in a regulatory feedback loop in MME 
expression. 
 
To further explore the role of MME in the inflammatory response, we compared 
primary human abdominal subcutaneous and omental (visceral) preadipocytes to 
stimulation of IL1β, substance P, or amyloidβ in the absence or presence of the 
MME inhibitor Omapatrilat (Robl et al., 1997). Omapatrilat alone did not 
significantly affect the RNA expression of inflammatory markers MCP1 and IL6 
(Figure 9). Compared to subcutaneous preadipocytes, the omental preadipocytes 
showed a trend of increased RNA expression of MCP1 and IL6 in response to 
IL1β (Figure 9). Substance P did not show any statistically significant changes in 
MCP1 and IL6 RNA expression with or without Omapatrilat (Figure 9). 
Interestingly, amyloidβ with Omapatrilat decreased the RNA expression of MCP1 
and IL6 relative to amyloidβ alone in subcutaneous preadipocytes (Figure 9). 
This decrease in inflammatory response may be related to the anti-inflammatory 
effects Omapatrilat has been shown in vivo (Pu et al., 2005). 
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MME perturbs insulin signaling in white preadipocytes and regulates the 
expression of the insulin receptor subunits 
MME is known to have crosstalk with insulin and IGF1 signaling by regulating 
signaling through PTEN/PI3K/AKT in a Casein Kinase 2 (CSNK2) dependent 
manner (Siepmann et al., 2010). However, the effects of MME on the insulin 
receptor tyrosine kinase have not been studied. To determine the effects on 
insulin receptor and downstream insulin signaling, immortalized HN 
subcutaneous white preadipocytes were transduced with MME siRNA for 48-
hours before insulin signaling experiments (Figure 10A). Protein levels of MME 
were reduced by 99% (p < 0.05) in the knockdown cells (Figure 10B). This 
resulted in a 2-fold increase in the levels of insulin receptor α (IRα) subunit as 
determined by Western blotting (Figure 10C). Interestingly, the level of Insulin 
receptor β (IRβ) subunit showed a trend to decrease by MME knockdown (Figure 
10D). This was paralleled by an even more marked decrease in insulin 
stimulation of insulin receptor phosphorylation at the Tyr1150/1151 site in the 
receptor kinase domain in the knockdown (Figure 10E). Total IRS1 and AKT 
protein levels were slightly increased after insulin stimulation, while 
phosphorylation of IRS1 at Tyr612 and AKT at Ser473 were decreased by 30% 
and 99% in the MME knockdown (Figure 10F-I). Total ERK and ERK 
phosphorylation in response to insulin stimulation were unchanged in the 
knockdown (Figure 10J-K). 
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To determine the contribution of the enzymatic activity of MME to these changes 
in insulin signaling, immortalized HN subcutaneous white preadipocytes were 
treated with Omapatrilat, an MME enzymatic inhibitor, for 48 hours before insulin 
stimulation. Interestingly, Omapatrilat treatment resulted in a ~2-fold increase in 
MME protein levels (p<0.05) (Figure 10B), but there was no change in protein 
levels of the insulin receptor α- or β-subunits (Figure 10C-D). Similarly, there was 
no change in the protein levels of the downstream proteins IRS1, AKT, and ERK 
(Figure 10F,H,J). Likewise, insulin-stimulated phosphorylation the insulin 
receptor and IRS1 were unchanged (Figure 10E,G), while phosphorylation of 
AKT and ERK were slightly increased compared to untreated insulin-stimulated 
control (Figure 10I,K).  
 
To further explore the role of MME on insulin signaling, immortalized HN 
subcutaneous white preadipocytes were transiently transduced with either MME 
(full length 750 amino acid protein) or GFP driven by CMV promoter for 48-hours 
before insulin signaling (Figure 11A). Knockdown with siRNA was also performed 
in parallel to confirm reproducibility. Again, knockdown of MME results in a 1.4-
fold increase in IR α-subunit but a 2-fold decrease in IR β-subunit 
autophosphorylation, which was paralleled by a ~30% decrease in insulin-
stimulated AKT phosphorylation. Overexpressing MME, on the other hand, did 
not affect IRα protein levels (Figure 11B-C). This was paralleled by a decrease in 
pIR levels (Figure 11D). Total IRS1, AKT, and ERK levels were decreased in the 
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overexpression, as was the phosphorylation of both IRS1 and AKT in the MME 
overexpression compared to the control GFP overexpression after insulin 
stimulation (Figure 11E-I). Taken together, these results demonstrate that normal 
levels of MME expression are required for insulin signaling, and that MME can 
regulate insulin signaling at the level of the insulin receptor, at least in part, by 
modulating the levels of IR protein and altering the ratio of α and β subunits. 
 
MMEKO preadipocytes have impaired insulin signaling 
MMEKO mice have been shown to have age-dependent obesity phenotype, with 
relatively young mice (age < 15 weeks) having a very mild to no phenotype and 
old mice (age > 36 weeks) having marked obesity under chow diet (Becker et al., 
2010; Standeven et al., 2011). In our colony, at 20 weeks, MMEKO mice on 
chow diet showed no difference in body weight compared to C57BL/6 controls 
(Figure 12A). A glucose tolerance test (GTT) at that time showed no difference 
from control (Figure 12B). However, an insulin tolerance test (ITT) showed a 
more marked reduction in circulating blood glucose in response to an i.p. 
injection of insulin in the MMEKO (Figure 12C), indicating increased insulin 
sensitivity in MMEKO mice compared to controls.  
 
To investigate whether there were any early cellular changes in insulin response, 
subcutaneous (inguinal) and visceral (epididymal) preadipocytes of 12-week old 
control and MMEKO mice were subjected to in vitro insulin treatment (Figure 
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13A). As expected, the levels of MME were markedly lower in the MMEKO mice 
and epididymal preadipocytes compared to WT and subcutaneous preadipocytes 
(Figure 13B). Consistent with in vitro knockdown studies, the levels of IRα were 
increased in the MMEKO preadipocytes, although in the subcutaneous 
preadipocytes, but not perigonadal preadipocytes, IRβ levels were also increased 
(Figure 13C-D). Again, this was also met with a reduction in insulin-stimulated 
pIR and pAKT in MMEKO preadipocytes, especially in the subcutaneous WAT 
depot (Figure 13E-G). As before, levels of total ERK and pERK in the MMEKO 
preadipocytes compared to WT were largely unchanged (Figure 13H-I). 
 
MME may regulate the internalization and cellular localization of the insulin 
receptor 
Insulin receptor internalization is one of the major methods to modulate insulin 
signaling and can lead to either recycling or degradation of the insulin receptor 
(Bergeron et al., 2016). Thus, we examined the acute internalization of the insulin 
receptor after insulin stimulation in knockdown or overexpression of MME protein 
levels. Total surface proteins in immortalized HN subcutaneous white 
preadipocytes were labeled with biotin after insulin stimulation. Immunoblotting 
was used to assess the internalization of the insulin receptor at 0, 30, and 120 
min post insulin stimulation in control and knockdown cells (Figure 14A). The 
levels of MME protein were decreased by 99% in the knockdown (Figure 14B). 
Insulin receptor phosphorylation (pIR) increased as a function of time in both the 
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knockdown and control (Figure 14C). As before, the MME knockdown showed a 
trend of higher basal pIR (0 min) and lower insulin-stimulated pIR (120 min) 
(Figure 14C). The levels of biotinylated insulin receptor (biotin-IRβ) were lower in 
the MME knockdown at 120 min (Figure 14D). These results show that a 
reduction in MME expression caused an increase in insulin receptor 
internalization. 
 
To complement the MME knockdown, insulin receptor internalization was 
assessed after the overexpression of MME or GFP control (Figure 14E). The 
overexpression of MME showed the most robust changes at 0 min and 120 min 
compared to the GFP control (Figure 14F). As in the knockdown, insulin receptor 
phosphorylation showed a time-dependent increase with no statistically-
significant difference in the MME and GFP overexpressing cells at any time 
points (Figure 14G). Interestingly, the levels of biotin-IRβ showed that the MME 
overexpressing cells had a similar time-dependent pattern as the MME 
knockdown cells (Figure 14H).  
 
To determine whether MME overexpression may affect insulin receptor 
subcellular localization, we performed subcellular fractionation in immortalized 
HN subcutaneous white preadipocytes overexpressing GFP, MME, or a 
catalytically-deficient MME (MMEX) (Figure 15). These proteins were 
overexpressed and the cell lysates fractionated into cytosplasmic, membrane, 
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nuclear, chromatin, and cytoskeletal protein fractions using a kit and differential 
centrifugation. As expected, cells overexpressing WT MME or MMEX showed the 
highest expression of MME protein in the membrane fraction, with lesser 
amounts in the cytoplasmic and nuclear fraction. The levels of IR α-subunit are 
highest in the membrane fraction, although expression could be detected in the 
cytoplasmic and nuclear fraction as well. The overexpression of either MME or 
MMEX as compared to GFP overexpression did not significantly affect IRα 
localization in any subcellular fraction (Figure 15). Thus, changing the level of 
MME does not significantly alter insulin receptor subcellular localization. 
 
MME and insulin receptor do not co-immunoprecipitate 
To determine whether MME may directly interact with the insulin receptor, we 
performed immunoprecipitation of MME and Insulin Receptor (IR) FLAG tagged 
on the C-terminus of the IRβ subunit transduced into immortalized murine brown 
IR/IGF1R double knockout preadipocytes (Boucher et al., 2010). Under normal 
growth (in media containing 10% fetal bovine serum), MME was not detected in 
the immunoprecipitate of FLAG-tagged IR, although phosphorylated IRS1 was 
detected as a positive control (Figure 16A). Similarly, in cells which had been 
serum-starved followed by 15-min insulin stimulation, MME could not be detected 
in the immunoprecipitate of the FLAG-tagged IR (Figure 16B). These results 
suggest that MME and the insulin receptor do not have a direct protein-protein 
interaction.  
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To assess whether MME and the insulin receptor might have any more indirect 
interaction, we analyzed the human protein-protein interactome (PPI) as defined 
in the Biological General Repository for Interaction Datasets (BioGRID) (Chatr-
Aryamontri et al., 2017). Again, the human PPI showed no direct interaction 
between MME and the insulin receptor (INSR). The calculated shortest paths 
showed that there may be at least two intermediate proteins in between MME 
and INSR (Figure 17). For example, one possible path (i.e. protein complex) 
between MME and INSR would be through Caveolin 1 (CAV1) and Flotillin 2 
(FLOT2), both of which are involved in endocytosis. Taken together, these 
results suggest that instead of a direct interaction, MME may affect insulin 
receptor by a protein complex involving at least two intermediate proteins. 
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Discussion 
Adipose tissue shows remarkable regional differences in multiple phenotypic 
characteristics including inflammatory response, insulin sensitivity, and metabolic 
behavior. Here, we show that one of the most significant differentially expressed 
proteins between subcutaneous and visceral preadipocytes is in the protein 
MME. More importantly, MME appears to modulate the inflammatory response 
and insulin signaling cascade in white preadipocytes. In particular, reducing MME 
expression increases the expression of pro-inflammatory genes in subcutaneous 
white preadipocytes. Similarly, we find that perturbations in MME expression 
differentially regulate the insulin receptor subunits. Thus, knockdown of MME 
increases the expression of IRα subunit but not IRβ subunit. This is associated 
with an increase in basal and decrease in insulin-stimulated IR signaling. These 
results suggest that MME is not only a marker of subcutaneous versus visceral 
preadipocytes, it is also a regulator of adipose insulin signaling and inflammatory 
response. 
 
MME has been shown to have at least three distinct transcripts in humans 
producing the same 750-bp protein product (Shipp et al., 1988). The most recent 
human genome build (GrCh38) has up to 18 different transcripts (coding, non-
coding, and predicted) from the MME locus. In rats these mRNA species have 
been shown to have tissue-specific expression driven by different promoters 
resulting in unique 5’ untranslated regions (Li et al., 1995). Truncated transcripts 
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of MME have been reported in previous studies (Llorens-Cortes et al., 1990; 
Iijima et al., 1992). A truncated form of MME missing exon 16 was identified in 
human lung tissue and reported to have significantly impaired enzymatic activity 
(Iijima et al., 1992). There are also differences in glycosylation of MME in 
different tissues resulting in tissue-specific differences in molecular weight of 
MME ranging from 85 to 110 kDa (Relton et al., 1983). Our data show differential 
exon-usage in MME between human subcutaneous and omental preadipocytes 
in the extracellular N-terminal peptidase domain (exons 12 and 14), suggesting 
distinct tissue-specific regulation of MME isoforms. 
 
In terms of its protease activity, MME has a broad range of substrates being able 
to target glucagon, bradykinin, GLP1, and several other classes of circulating 
small molecules (Webster et al., 2014). MME has been shown to target free 
insulin B-chain (Sexton et al., 2012), although whether MME could target and 
degrade the insulin receptor is unknown. MME may be part of a larger class of 
extracellular proteases important in regulating insulin signaling. For example, β-
secretase 2 (BACE2), another extracellular protease that shares at least one 
common substrate with MME (amyloid precursor protein), has been shown to 
regulate insulin receptor (IRβ) internalization in pancreatic β-cells (Casas et al., 
2010). Furthermore, mice with functionally-inactive BACE2 show increased β-cell 
mass and increased circulating insulin levels (Esterházy et al., 2011). 
Interestingly, the closely related homologue BACE1 does not affect insulin 
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receptor internalization (Casas et al., 2010). Thus, the MME-dependent 
regulation of insulin signaling may share a mechanism similar to BACE2, where 
proteolytic cleavage of INSR is modulated. 
 
The effects of MME on insulin signaling likely are responsible for its documented 
effects on adipogenesis. For example, MME overexpression has been shown to 
potentiate adipogenesis by activating the AKT-PI3K pathway (Kim et al., 2017). 
Mice with knockout of MME do not show defects in adipose tissue development, 
at least up to 20 weeks of age (Standeven et al., 2011). However, MMEKO mice 
on chow diet develop obesity evident at around 36 weeks of age (Becker et al., 
2010). We find that a reduction in MME expression increased basal insulin 
receptor phosphorylation and decreased insulin-stimulated receptor 
phosphorylation. Thus, one potential resolution for these counterintuitive 
observations is that MMEKO adipose tissue has altered insulin response, which 
can contribute to obesity after sufficient ageing. 
 
Elevated circulating levels of soluble MME are associated with increased BMI 
and HOMA-IR (Standeven et al., 2011). Also, pharmacological treatment of rats 
with MME inhibitors has been associated with increased insulin sensitivity (Arbin 
et al., 2003). This may be due to increased circulating MME-degraded hormones 
such as bradykinin (Arbin et al., 2003; Wang et al., 2003). MME has also been 
shown to be secreted on exosomes from adipose-derived stem cells (Katsuda et 
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al., 2013). Thomou et al. have shown that exosomes released from adipose 
tissue may regulate gene expression in distal tissues (Thomou et al., 2017); 
while this activity has been shown to be related to exosomal miRNAs, this may 
also be related to exosomal-bound MME. In effect, subcutaneous-adipose-
derived circulating MME may have distal regulatory effects on peripheral tissue. 
Thus, MME may have a distinct cellular role to regulate insulin signaling at the 
level of the insulin receptor and a somewhat distinct systemic effect to regulate 
whole-body insulin sensitivity by degrading several small peptide hormones. 
Determining how to modify each of these hierarchical roles will be crucial in 
therapeutic interventions for adipose-associated diseases mediated through 
MME. 
 
In regards to regional variation in metabolic behavior of adipose tissue, 
subcutaneous adipose tissue transplantation has been shown to reprogram 
visceral adipose tissue to have subcutaneous-like phenotypic behavior, whereas 
visceral-to-subcutaneous transplantation does not promote a more detrimental 
phenotype (Tran et al., 2008; Tran and Kahn, 2010). MME, as a membrane-
bound protease, can modify the local milieu in a substrate-specific manner in an 
adipose transplantation, whereas the absence of MME would not worsen the 
depot. Thus, MME may also be involved in adipose tissue reprogramming by 
degrading the appropriate hormones to promote a metabolically-beneficial 
phenotype. 
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Although we have focused on MME as one of the central differences between 
subcutaneous and visceral preadipocytes, the gene expression in both human 
and mouse datasets showed several other distinct differences. For example, 
another differentially expressed gene, 4-aminobutyrate aminotransferase 
(ABAT), has been shown to be differentially expressed between brown and white 
adipocytes (Ramirez et al., 2017) and may be involved in the maintenance of 
mitochondria (Besse et al., 2015), which are much higher in brown adipocytes 
than in white adipocytes. Thus, ABAT may also be involved in the metabolic 
differences within different types of white adipocytes, namely between 
subcutaneous and visceral adipocytes. Similarly, the remaining differentially 
expressed genes, Integrin beta 8 (ITGB8) and Junction Adhesion Molecule A 
(F11R), may play an as-of-yet identified role in the phenotypic differences 
between depot-specific adipocytes. 
 
In summary, we have shown MME has distinct roles in white preadipocytes. 
Functionally in a systemic context, MME can target a broad class of inflammatory 
cytokines, thus its high expression in subcutaneous preadipocytes serves to 
decrease inflammatory response in relation to visceral preadipocytes. More 
importantly, we have shown that MME can regulate receptor trafficking, 
suggesting a cellular role in insulin signaling. Thus, MME in preadipocyte and 
adipose tissue may serve as a potential therapeutic target to modulate insulin 
sensitivity and inflammatory response in a depot-specific manner. 
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Figures 
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Figure 5 RNA-Seq of preadipocytes revealed depot-specific signatures. 
Human subcutaneous, omental, and mesenteric preadipocyte primary cultures 
were grown to confluency, harvested for RNA, and subjected to RNA-seq to 
generate gene expression profiles. For mouse gene expression profiles, inguinal 
and epidydimal preadipocyte primary cultures were grown to confluency, 
harvested for RNA, and subjected microarray analysis. (A) Principal component 
analysis of human subcutaneous, mesenteric, and omental gene expression 
profiles shows clustering by depot. (B) Principal component analysis of inguinal 
and epidydimal gene expression profiles shows clustering by depot. (C) 
Differential gene expression followed by Gene Set Enrichment Analysis (GSEA) 
revealed a set of pathways differentially expressed between subcutaneous and 
visceral preadipocytes in human and mouse tissue. SC = abdominal 
subcutaneous. MES = Mesenteric. OM = Omental. Epi = Epididymal. SubQ = 
Inguinal. N=3-5 
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Figure 6 MME is a highly differentially-expressed gene between visceral 
and subcutaneous preadipocytes. The 20 significant pathways were analyzed 
to reveal genes found multiple pathways. (A) A total of four genes (ABAT, ITGB8, 
MME, and F11R) were significant in multiple pathways. (B) RNA-seq expression 
of Membrane Metallo-Endopeptidase (MME) in subcutaneous and visceral 
preadipocytes (Omental = OM, Mesenteric = MES). (C) Microarray expression of 
MME in mouse subcutaneous (SubQ) and visceral preadipocytes (Epi).  
Asterisks indicate p < 0.05 by moderated t-test (limma). N=3-5. Bars indicate 
mean ± s.e.m. 
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Figure 7 RNA-seq reveals differential exon usage in MME between 
subcutaneous and omental preadipocytes. Exon-level count tables were 
generated by HTSeq for omental and subcutaneous RNA seq gene expression 
profiles. Differential exon usage was performed with DEXSeq. (A) The relative 
exon usage map shows at least one differentially-expressed exon in MME 
between subcutaneous (red) and omental (black) preadipocytes. The transcript 
table of the detected exons (i.e. at least 1 unique read mapped to the region) 
showed at least one exon (exon 12) was comparatively higher in omental 
preadipocytes than in subcutaneous preadipocytes after normalizing to the 
average expression of every other exon. (B) Absolute qPCR was performed with 
exon-specific primer sets and copy number determined by a standard generated 
with synthetic template (see methods). Exon 14 (ENSE00001019488) was 
relatively higher in omental preadipocytes rather than exon 12. Asterisk in (A) 
indicates p ≤ 0.05 by a likelihood ratio test. Asterisks in (B) indicate p ≤ 0.05 by 
Student’s t-test. N=3-4. Bars indicate mean ± s.e.m. 
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Figure 8 Knockdown of MME increases the expression of pro-inflammatory 
markers IL6 and MCP1 in subcutaneous white preadipocytes. Immortalized 
human neck white subcutaneous preadipocytes were transiently transfected with 
siRNA targeting MME and harvested for RNA or protein. (A) qPCR of transfected 
cells shows a significant reduction of MME mRNA after 72 hours post-
transfection of 100 pmol siRNA targeting MME. (B) Western blot on protein 
lysates collected at 24-hrs and 72-hrs after transfection showed efficient 
knockdown of MME protein by 24-hours. (C) Transient transfection with MME 
siRNA was performed for 24-hours followed by serum-starvation for 24-hours. 
Then, treatment with IL1β (5 ng/μL), Substance P (100 nM), or Amyloidβ 
aggregates (20 μM) was performed for 24-hours before RNA extraction and 
qPCR of IL6, MCP1, and TNFα. Knockdown of MME increases expression of 
pro-inflammatory markers IL6 and MCP1 in response to substance P and 
Amyloidβ aggregates. Asterisks indicate p <= 0.05 by Student’s t-test. N=3. Bars 
indicate mean ± s.e.m. 
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Figure 9 Pharmacological inhibition of MME does not significantly affect 
the expression of pro-inflammatory markers MCP1 and IL6 in 
subcutaneous or visceral preadipocytes. Confluent cultures of primary human 
abdominal subcutaneous and omental preadipocytes were serum-starved for 24-
hours. Then, treatment with IL1β (5 ng/μL), Substance P (100 nM), Amyloidβ 
aggregates (20 μM), or Omapatrilat (1 μM) was performed for 24 hours before 
RNA-harvest and qPCR of MCP1 and IL6. Asterisks indicate p ≤ 0.05 by 
Student’s t-test. N=3. Bars indicate mean ± s.e.m.  
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Figure 10 Knockdown of MME perturbs insulin signaling and increases IRα 
but not IRβ. Immortalized human neck white subcutaneous preadipocytes were 
transiently transfected with siRNA targeting MME, non-targeting siRNA, or 
Omapatrilat for 48 hours. Cells were starved for 24 hours before a 20-minute 
insulin stimulation (100 μM) followed by protein isolation and western blot. (A) 
Western blot of knockdown of MME or treatment with Omapatrilat in immortalized 
subcutaneous preadipocytes. (B-K) Densitometric analysis of protein levels. The 
levels of unphosphorylated proteins were grouped by treatment (Control, MME 
KD, or Ompatrilat). The levels of phosphorylated proteins were grouped by 
treatment and insulin stimulation (black = no insulin, grey = 20 min after 100 μM 
insulin). Omapatrilat = dual ACE/MME pharmacological inhibitor. Asterisks 
indicate p ≤ 0.05 by Student’s t-test. N=3 or 6. Bars indicate mean ± s.e.m. 
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Figure 11 Overexpression of MME does not show a reciprocal perturbation 
on insulin signaling compared to the MME knockdown. Immortalized human 
neck white subcutaneous were transiently transduced with either MME (full 
length 750 amino acid protein) or GFP driven by CMV promoter for 48 hours 
before insulin signaling. Knockdown was performed by a transient transduction of 
siRNA targeting MME or GFP 48 hours before insulin signaling. Cells were 
starved for 24 hours before a 20-minute insulin stimulation followed by protein 
isolation and western blot. (A) Western bot of knockdown and overexpression of 
MME showed marked changes in the insulin signaling cascade. (B-I) 
Densitometric analysis of protein levels. The levels of unphosphorylated proteins 
were grouped by treatment (Control, MME KD, MME OE, or GFP). The levels of 
phosphorylated proteins were grouped by treatment and insulin stimulation (black 
= no insulin, grey = 20 min after 100 μM insulin). Asterisks indicate p ≤ 0.05 by 
Student’s t-test. N=3 or 6. Bars indicate mean ± s.e.m. 
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Figure 12 20-week old MMEKO mice are more insulin sensitive compared to 
control mice. (A) MMEKO mice (red), compared to control littermates (black), 
showed no difference in weight at 20 weeks. (B) A GTT performed on 20-week 
old mice showed a slight increase in glucose levels at 15 min in MMEKO mice. 
(C) An ITT performed on the same cohort at 22-weeks old showed a marked 
reduction in glucose levels in MMEKO mice. Asterisks indicate p ≤ 0.05 by 
Student’s t-test. N=3. Bars indicate mean ± s.e.m. 
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Figure 13 Subcutaneous and perigonadal MMEKO preadipocytes show 
impaired insulin signaling. MMEKO and control (wild-type C57BL/6) mice aged 
12-weeks were sacrificed for in vitro insulin signaling. The stromal vascular cells 
(preadipocytes) from the subcutaneous (inguinal) and visceral (perigonadal) 
adipose depots were isolated. Cells were starved for 4 hours before a 20-minute 
insulin stimulation followed by protein isolation and western blot. (A) Western blot 
of protein of subcutaneous and perigonadal MMEKO preadipocytes showed 
impaired response among different insulin-signaling proteins. (B-I) Densitometric 
analysis of protein levels. The levels of unphosphorylated proteins were grouped 
by adipose depot (PG = Perigondal, SC = Subcutaneous) and genotype (black = 
Control, grey = MMEKO). The levels of phosphorylated proteins were grouped by 
adipose depot, genotype, and insulin stimulation (- = no insulin, + = 20 min after 
100 μM insulin). Asterisks indicate p ≤ 0.05 by Student’s t-test. N=3. Bars 
indicate mean ± s.e.m. 
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Figure 14 Knockdown of MME may increase the rate of internalization of 
the insulin receptor. Immortalized human neck white subcutaneous were 
transiently transduced with either siRNA targeting MME (MMEKD), non-targeting 
siRNA (Control), pCMV-MME (MMEOE), or pCMV-GFP (GFP) for 48 hours 
before insulin signaling and receptor internalization experiments. Cells were 
starved for 24 hours before a 0, 30-min, or 120-minute insulin stimulation 
followed by surface-receptor labeling (biotinylation), protein isolation, and 
western blot. (A) Western blot of MME, pIR, biotin-IRβ, and actin in the MME 
knockdown. (B-C) Densitometric analysis of protein levels. Proteins were 
grouped by treatment (Control = black, MMEKD = red) and time (0, 30, or 120 
min after 100 μM insulin stimulation). (E) Western blot of MME, pIR, biotin-IRβ, 
and actin in the MME overexpression. (F-H) Densitometric analysis of protein 
levels. Proteins were grouped by treatment (GFP = black, MMEOE = red) and 
time (0, 30, or 120 min after 100 μM insulin stimulation). Asterisks indicate p ≤ 
0.05 by Student’s t-test. N=3. Bars indicate mean ± s.e.m. 
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Figure 15 MME overexpression does not affect insulin receptor cellular 
localization. Immortalized human neck white subcutaneous were transiently 
transduced with either pCMV-GFP, pCMV-MME, or pCMV-MMEX for 48 hours 
before subcellular protein fractionation and western blot. Wild-type MME and 
catalytically-deficient MME (MMEX) was overexpressed as expected and 
primarily localized to the membrane. Overexpression of MME or MMEX did not 
affect IRα localization. Cyto = Cytoplasm, Mem = Membrane, Nuc = Nuclear, 
Chrom = Chromatin, CytoS = Cytoskeleton. N=1. 
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Figure 16 MME does not form a protein complex with the insulin receptor. 
Immortalized IR/IGFR double-knockout murine brown preadipocytes were 
transiently transduced with either pCMV-MME alone or pCMV-MME and pCMV-
IR-3XFLAG for 48 hours before insulin signaling, protein isolation, and 
immunoprecipitation followed by western blot. (A) Western blot of protein lysate 
and the immunoprecipitation of IR-FLAG in IR/IGFR double knock brown 
preadipocytes in serum-fed media. (B) Western blot of protein lysate and the 
immunoprecipitation of IR-FLAG in IR/IGFR double knock brown preadipocytes 
after serum-starvation followed by 100 μM insulin stimulation. N=2.  
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Figure 17 Protein-protein interaction network between MME and INSR. The 
shortest paths in between MME (bottom node) and INSR (top node) was 
determined in the PPI as defined in BioGRID. RNA-seq from subcutaneous 
adipose tissue from ENCODE was plotted on the nodes. One possible path is 
INSR-CAV1-FLOT2-MME, which are proteins found on endocytic vesicles. 
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Chapter 3: Network Analysis of Single-Cell RNA seq Reveals Metabolic 
Heterogeneity of Human White Adipocytes  
Abstract 
White adipose tissue is a major site of energy storage and plays a significant role 
in physiological homeostasis and metabolic disease. Adipocytes are known to 
exhibit both variability and heterogeneity. Network biology and single cell 
sequencing are promising new technologies that allow us to gain a deeper 
understanding of both the differentiation program of adipogenesis and the 
possible metabolic and transcriptional heterogeneity in this tissue. By analyzing 
single cell RNA-seq profiles of human subcutaneous preadipocytes during 
adipogenesis in vitro, we have identified at least two distinct classes of white 
adipocytes. These differences in gene expression are separate from the process 
of browning and beiging, but are consistent with gene and metabolic signatures 
in clonally-expanded human white preadipocyte cell lines. Using a novel systems 
biology approach, we have also identified a connected network module of zinc 
finger proteins that appears expressed in one of the classes of adipocytes and is 
potentially involved in regulating adipogenesis. Targeting these proteins using 
CRISPR confirms their functional importance in adipogenesis. These findings 
suggest new subclasses of white pre-adipocytes and a novel set of zinc fingers 
involved in regulation of adipogenesis. 
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Graphical Abstract 
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Introduction 
Adipose tissue is a heterogeneous organ and composed of several cell types, 
including adipocytes, stem cells, endothelial cells, and various blood cells (Lynes 
and Tseng, 2017). Functional differences between adipose tissue depots are, in 
part, due to the relative abundance of different cell types (Gesta et al., 2007). 
Different white adipose depots have distinct physiological functions associated 
with their anatomical location. Accumulation of visceral (intra-abdominal) adipose 
tissue is associated with insulin resistance and metabolic syndrome (Ibrahim, 
2010; Tchkonia et al., 2013), whereas accumulation of subcutaneous adipose 
tissue is metabolically benign and may be even associated with increased insulin 
sensitivity (Tran and Kahn, 2010). Other adipose depots, such as marrow 
adipose tissue, or pericardial or intraarticular adipose tissue, also have different 
endocrine and metabolic profiles (Lee et al., 2013b; White and Tchoukalova, 
2014; Cawthorn et al., 2014). Determining the mechanisms for these phenotypic 
differences could lead to development of novel therapies for diabetes, obesity, 
and their associated morbidities.  
 
At least three distinct developmental types of adipocytes have been identified: 
white, brown, and beige adipocytes (Sanchez-Gurmaches and Guertin, 2013). 
White adipocytes contain a large unilocular lipid collection and have the primary 
function of energy storage (Rosen and Spiegelman, 2006). Brown adipocytes, in 
contrast, contain multilocular lipid droplets and are specialized for energy 
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expenditure through the presence of uncoupling protein 1 (UCP1) (Lynes and 
Tseng, 2015). Beige adipocytes also express UCP1 and have multilocular lipid 
droplets, but are found mixed in white adipose depots. Beige fat can be induced 
(e.g. by β-adrenergic stimulation and exercise) for energy expenditure (Sparks et 
al., 2012).  
 
The formation of new adipocytes, adipogenesis, is one of the most well-
characterized cellular models of differentiation. The process depends on several 
key transcriptional regulators including PPARγ, CEBPβ, and various Krüppel-like 
Factors (KLFs) (Farmer, 2006; Guo et al., 2015; Wang et al., 2015; Sanchez-
Gurmaches et al., 2016). Advances in technologies such as high-throughput 
sequencing have revealed additional transcriptional regulators ranging from zinc 
finger proteins (ZFPs/ZNFs) to long non-coding RNAs (Meruvu et al., 2011; Zhao 
et al., 2014; Longo et al., 2018). Each of the different types of adipocytes also 
have distinct transcription factors,  such as ZFP423 for white adipocytes (Shao et 
al., 2016) and EBF2 for brown/beige adipocytes (Rajakumari et al., 2013). The 
transcriptional networks specific to beige adipocytes are less clear, but appear to 
be similar to transcriptional networks in brown adipocyte development (Wang and 
Seale, 2016). Recently, we and others have presented evidence for 
heterogeneity of white adipocytes with regard to metabolic function. For example, 
Lee et al. shown that TBX15 is a marker for a subgroup of white adipocytes with 
high glycolytic activity (Lee et al., 2017).  
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Previous work working to identity cellular heterogeneity in other biological 
contexts have used a multitude of approaches to elucidate cellular heterogeneity 
including mass cytometry, lineage tracing, and various –omics profiling. Among 
them, high-throughput analyses of mRNA in single cells is an emerging approach 
to studying cellular heterogeneity. Such single-cell methodologies have been 
used to elucidate novel cell types in the brain (Pollen et al., 2014; Usoskin et al., 
2015; Campbell et al., 2017), inner ear (Burns et al., 2015), intestine (Lyubimova 
et al., 2015), bone marrow (Amir et al., 2013), and various types of cancer 
(Puram et al., 2017; Colacino et al., 2018; Horning et al., 2018). Single-cell gene 
expression has been used effectively to identify new subclasses of cell types 
using unsupervised clustering techniques on data obtained from different 
physiological conditions in model organisms or patients (Alizadeh et al., 2000; 
Lein et al., 2007).  
 
Single-cell RNA sequencing is an ideal technique to profile gene expression of 
heterogeneous cell populations obtained from a single tissue such as blood or 
brain. Adipose tissue, however, poses a peculiar challenge to single-cell RNA-
sequencing as adipocytes can be as large as 200 nm in diameter in vivo and 
over 95% triglycerides, limiting microfluidic approaches. Combining clustering 
gene expression with network analysis has been shown to be more sensitive to 
identify differences in biological processes in different cells types (Chuang et al., 
2007; Liu et al., 2007). In this study, we elected to analyze single-cell RNA-seq 
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during a time-course of differentiation of human subcutaneous preadipocytes to 
identify potential heterogeneity in this population. We have also combined the 
single cell RNA-seq data with network analysis to identify subpopulations of cells 
and novel regulatory genes that potentially play mechanistic role in cell fate. 
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Methods 
Base-level analysis of single-cell RNA-seq 
Single-cell RNA seq profiles of abdominal subcutaneous human preadipocytes 
undergoing adipogenesis were obtained as previously described (Soumillon et 
al., 2014). In these data, the primary human preadipocytes were taken from 
commercially-available lipoaspirates (single donor; Life Technologies) sorted by 
fluorescence-activated cell sorting (FACS) based on the positive selection (i.e. 
express the proteins) for CD29, CD44, CD73, CD90, CD105, CD16, and 
negative selection (i.e. do not express) against CD14, CD31, CD45, Lin1. The 
cells were maintained in 2% reduced serum growth media for up to 3 passages 
(MesnPro, Life Technologies). For differentiation, cells were grown to either 80% 
or 100% confluency and then incubated with differentiation media (StemPro 
adipogenesis differentiation media, Life Technologies) for 7 or 14 days.  
 
For single-cell sorting, culture plates were treated with trypsin, and the released 
cells pelleted by centrifugation at 1000 rpm for 5 min. Pellets were resuspended 
with Dulbecco’s phosphate-buffered saline (DPBS), stained with Hoeschst 
33342, and individual cells FACS sorted into prepared 384-well plates. Library 
generation and RNA-sequencing was performed as described in (Soumillon et 
al., 2014). For data analysis, we used PAGODA (Fan et al., 2016) to analyze the 
expression profiles in experiment ‘D1’ (differentiation beginning at 80% 
confluency), ‘D3’ (differentiation beginning at 100% confluency), and ‘D3_bulk’ 
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(RNA-seq on 8 samples of confluent, multi-cellular cultures) (GSE53638). Single 
cell differential gene expression was performed with the package SCDE 
(Kharchenko et al., 2014). 
 
Cell culture and adipogenesis 
Human preadipocyte cell lines were also obtained from superficial fat depots in 
the neck of patients undergoing cervical spine surgery (Xue et al., 2015; Kriszt et 
al., 2017). These cell lines were immortalized with stable transfection of human 
telomerase (TERT) as previously described (Xue et al., 2015). Cells were 
passaged at 80% confluency and maintained in growth media (DMEM-H, 
10%FBS, 1% penicillin-streptomycin). For differentiation, cells were grown to 
100% confluency and incubated with pre-induction media (DMEM-H, 2% FBS, 
1% Pen-Strep, 0.2% normocin, 500 nM insulin, 2 nM T3, 1 μM rosiglitazone) for 
days 1-6, followed by addition of induction media (DMEM-H, 2% FBS, 1% Pen-
Strep, 0.2% normocin, 500 nM insulin, 500 μM IBMX, 2 nM T3, 1 μM 
rosiglitazone, 33 μM biotin, 17 μM pantothenate, 100 nM dexamethasone, and 
30 μM indomethacin) for 7-20 days. 
 
Oil red O staining 
Clonal human neck-derived subcutaneous preadipocytes were differentiated to 
the indicated time points (either 14 days or 20 days) before fixation and staining. 
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Cells were washed with 1X PBS and fixed with 10% formalin for 1 hour at room 
temperature. Oil red O (ORO) working solution was prepared by mixing ORO 
stock solution (3 mg/mL in isopropanol) and deionized water at a 3:2 ratio and 
filtered through Whatman paper. Cells were washed with deionized water, 
equilibrated with 60% isopropanol for 5 min, and stained with ORO working 
solution for 1 hour. Then, wells were washed with water until clear and 
visualized. For quantification, ORO was eluted with 100% isopropanol for 30 min 
and absorbance measured at 510 nm. 
 
RNA-seq of clonal preadipocytes 
Clonal human neck-derived subcutaneous preadipocyte cell lines were 
maintained in culture and grown to 100% confluency before RNA harvest. Total 
RNA was harvested and purified with Trizol reagent. RNA quality was measured 
on the Agilent 2100 Bioanalyzer to ensure RIN values were greater than 8.0. To 
construct libraries for sequencing, we used the NEBNext Ultra Directional Library 
Prep Kit and Poly-A selection kit (New England Biolabs). Library enrichment and 
multiplexing was performed using the NEBNext High-Fidelty PCR Master Mix (14 
cycles of PCR) and NEBNext Multiplex Oligos.  
 
The cDNA libraries were multiplexed on the Illumina HiSeq 2000 and 2500. Raw 
50bp paired-end reads were aligned with STAR (v2.3.0e) (Dobin et al., 2013) to 
the human genome build hg19 and annotation file gencode v19. Raw counts 
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were extracted using HT-seq (v0.5.4). Analyses were carried out in R and 
various packages including DESeq2 (Love et al., 2014) and SCDE (Kharchenko 
et al., 2014). 
 
Subnetwork detection by integrating the protein-protein interactome and module 
detection 
In this paper, we deploy a novel network algorithm to analyze single cell RNA 
seq data in differentiating preadipocytes. We believe that the integration of 
network analysis and single cell RNA seq is a very promising new direction for 
understanding both modularity and heterogeneity of gene expression in complex 
biological processes. Our hypothesis is that the gene expression state of the cell 
is, in part, influenced by an underlying biological network defined by the 
interactivity between proteins. This hypothesis is consistent with a number of 
publications in system biology (Chuang et al., 2007; Liu et al., 2007; Karni et al., 
2009). This framework is different from using a regulatory network that captures 
protein-DNA interactions (Gardner et al., 2003; Faith et al., 2007). Our underlying 
network is a wiring diagram where the nodes are proteins and the edges are 
literature-reported experimentally-observed interactions. One limitation, however, 
is that these literature-reported interactions lack tissue specificity (Cerami et al., 
2011).  
 
Given our hypothesis, each gene expression profile of a single cell defines a 
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network snapshot. Papers that use a regulatory network framework for modeling 
gene expression (Faith et al., 2007; Camacho et al., 2018) attempt to recover the 
causal regulators of gene expression (Margolin et al., 2006; Marbach et al., 2012; 
Feizi et al., 2013). In contrast, we aim to produce a relatively simple 
representation capturing the activity of protein complexes or signaling pathways 
in different cells. In the simplest case, the goal is to explain the system behavior 
by predicting up-regulated and down-regulated modules and their activity in 
heterogeneous cell populations.  
 
The input to our algorithm is:  
a) A matrix containing the single-cell expression profiles in experiment ‘D1’ 
was first transformed to log scale (log2(UMI + 1)) and then transformed to 
z-scores. 
b) The input protein-protein interaction network was the union of all 
interactions in the network database Pathway Commons v5 (network 
named ‘Pathway Commons.5.All.EXTENDED_BINARY_SIF’) (Cerami et 
al., 2011).  
 
Integrating the two data sources, we can interpret the N single cell gene 
expression profiles as a set of N network snapshots in different time points of 
adipocyte differentiation. Each node (protein in the network) is associated with a 
score that corresponds to the differences in gene expression of the 
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corresponding gene in this cell as compared to distribution of all values of this 
gene in the data. The edges are unweighted in this paper, although the method 
can be generalized to edges associated with confidences as describe in STRING 
and related databases (Chatr-Aryamontri et al., 2017; Szklarczyk et al., 2017).  
 
The single-cell network snapshots can be described as a matrix of row vectors 
Y1, Y2, …, YN where each Yi correspond to a gene expression profile of a single 
cell. This yields a matrix where the columns are nodes in the network and the 
rows are network snapshots (gene expression profiles of cells).  
 
The goal of the algorithm is to represent the behavior of the network during 
differentiation as the activity profiles of relatively small connected components of 
the network. Within each network component, the activity is captured by a 
relatively simple explanation. For example, the activity of the network could be 
explained by a connected component where the gene expression of the genes is 
relatively high on the average, which could define a module associated or driving 
a state of differentiation. Alternatively, we may be able to identify a protein 
complex that consists of subunits of the same protein, such as the ribosome (a 
protein complex) and its many subunits (the proteins RPS2, RPS3, etc). 
 
Unlike standard statistical analysis that relies on methods such as piecewise 
multiple linear regression or clustering we add two relevant biological constraints:  
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a) The genes in each component are connected in the PPI network (module). 
b) The approximation we use to model the data in each component can be 
captured by a matrix method that can explain the activity of the 
component.  
c) The activity of each genes across the cells can be mathematically 
described as a linear function of multiple connected networks that the 
gene appears in. For example, the gene can be controlled by two 
networks: one network (pathway) could be activating and the other 
repressing.  
 
This approach extends the class of complex systems we can explain relatively 
succinctly with connected modules using matrix algebra. Our specific 
mathematical definition is shown below and the full algorithm is provided in the 
supplement. This general approach we describe allows a number of extensions 
and variants. For example, we can require the modules to be densely connected 
or impose other network constraints. We can also extend the algorithm to use 
different definitions of simple explanation of the data in each component. 
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CRISPR Knockouts 
To generate plasmids for CRISPR knockouts, we designed gRNAs via the 
software provided by the Zhang lab (crispr.mit.edu) to ZNF264 (F:5’- 
CACCGGGTGTCCAATGTTCGAGGGCAGG, R: 5’- 
AAACCCTGCCCTCGAACATTGGACACCC) , ZNF490 (F: 5’ 
CACCGGGCGGGCGGATTAAGAGGTCAGG, R: 5’- 
AAACCCTGACCTCTTAATCCGCCCGCCC) , ZNF587 (F: 5’- 
CACCGGGAGTACAGCGGCGCCATCTCGG, R: 5’- 
AAACCCGAGATGGCGCCGCTGTACTCCC) , and ZNF714 (F: 5’- 
CACCGTCGTCGAACCCAAAAGGCACAGG, R: 5’- 
AAACCCTGTGCCTTTTGGGTTCGACGAC). These oligos were annealed in a 
20-μL annealing reaction (100 μM forward oligo, 100 μM reverse oligo, 2 μL 10X 
T4 ligation buffer (New England Biolabs), 13 μL water, 1 μL T4 Polynucleotide 
Kinase) in a 3-step thermocycling protocol (1. 37° C for 30 min, 2. 95° C for 5 
min, 3. 95° C to 25° C at 5° C/min). These annealed oligos were cloned into 
pLentiCRISPRv2 (digested with BsmBI), transformed into DH5α chemically-
competent cells, and purified with a maxiprep (Qiagen). Transfection into 
preadipocytes was performed with lipofectamine 3000, and cells incubated for 48 
hours. Differentiation was carried out to day 14 or day 20, after which cell were 
fixed with 10% formalin for 1 hr. Oil red O staining was performed as described 
above. 
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Analysis of ZNF expression in a single-cell RNA seq dataset of adipogenesis, 
chondrogenesis, and osteogenesis 
We analyzed a single cell RNA seq data set containing profiles of the 
differentiation of fibroblasts into adipocytes, chondrocytes, and osteocytes 
(GSE37521) (Jääger et al., 2012). The normalized, pre-processed RNA-seq data 
were download from GEO and analyzed in R via the packages GEOquery (Davis 
and Meltzer, 2007), Limma (Ritchie et al., 2015), and Biobase (Gentleman et al., 
2004). For comparing the ZNF expression to FABP4, a marker of adipogenesis, 
for each cell, the max of ZNF264, ZNF490, ZNF587, or ZNF714 was used. 
 
Extracellular Flux Profiling 
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were 
measured using a Seahorse XF24 (Seahorse Bioscience). Cells were counted 
with a Cellometer® Vision (Nexcelom Bioscience) and seeded in 24-well 
Seahorse Cell Culture Microplates (60,000 cells/well) for 24 hours, or for 21 days 
when induced to differentiate (as described above). Each clonal cell line was 
seeded in duplicate or triplicate (one 24-well plate per subject). 1.5 h after the 
seeding in 100 µl medium (4.5g/L glucose DMEM, 10% FBS, 1% 
penicillin/streptomycin), an additional 150 µl medium were added to ensure 
optimal distribution of cells. 2 h prior to measurements, 150 µl was removed from 
each well, 900 µl of XF Assay Medium (1g/L glucose, 2mM L-glutamine, 2mM Na 
pyruvate) were added and then removed, before 400 µl were added for a total 
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volume of 500 µl and placing the plate at 37ºC with no CO2. Basal OCR and 
ECAR values for each replicate were normalized to amount of DNA in the 
corresponding well. DNA was extracted by washing cells with PBS, incubating in 
100 µl 50mM NaOH for 30 min, heating at 96ºC for 5 min, and adding 25 µl 1M 
Tris pH 6.5. DNA concentrations were measured by NanoDrop. OCR and ECAR 
in fully differentiated adipocytes were normalized to intracellular Oil Red O. 
 Basal glucose uptake was measured by intracellular incorporation of 
radioactive-labelled 3H-deoxy-glucose. Cells were seeded in 12-well plates 
(50.000 cells/well, duplicates) and cultured in DMEM containing 4.5g/L glucose, 
10% FBS and 1% penicillin/streptomycin for 48 hours, before washing cells twice 
with PBS and changing to 1g/L glucose DMEM with 5% FBS for 16 h. Cells were 
then washed once with PBS and once with KRH supplemented with 2.5mM 
pyruvate and 0.5% fatty acid free BSA, before incubation at 37ºC for about 3 h in 
1 ml of the glucose-free KRH. After two washes with PBS, the glucose-free KRH 
was replaced by 0.5 ml KRH/BSA containing 100µM 2-deoxy-glucose and 0.5µCi 
for 2 minutes, before placing the plates on ice to terminate glucose uptake. 400 
µl of each sample were transferred to scintillation tubes and 4 ml CytoScint 
scintillation fluid were added before rigorous shaking and measurement in a 
Beckman LS6500 scintillation counter. Disintegrations per unit time (DPM) were 
normalized to protein measured in 40 µl sample per well using BCA Protein 
Assay Kit (Pierce). 
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QPCR analysis 
For qPCR analysis, cDNA was synthesized from 500 ng RNA using the High 
Capacity Reverse Transcription Kit (Applied Biosystems). In 20 µl reactions, 2 µl 
RT-buffer, 0.8 µl dNTP mix, 2 µl random primers, and 1 µl MultiScribe RT were 
mixed together with RNA and nuclease-free water. The samples were incubated 
at 25ºC for 10 min, 37ºC for 2 h and 85ºC for 5 min. The cDNA was diluted 1:20 
in nuclease-free water. qPCR was performed using the CFX384 Real-Time 
System (BioRad). A master mix was prepared containing 5 µl 2X SYBR Green, 
0.1 µl forward primer, 0.1 µl reverse primer, and 2.3 µl nuclease-free water per 
sample, to which 2.5 µl cDNA template was added in a 384-well plate. The 
reaction was run by the following program: 95ºC for 3 min, then 40 cycles of 95ºC 
for 10 sec and 60ºC for 45 sec. Melting curve analysis (increments of 0.5ºC from 
60ºC to 95ºC) confirmed specificity of the primers. Mean target mRNA levels 
based on technical triplicates were calculated by the ΔΔCT method and 
normalized to the mRNA level of HPRT. 
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Results 
Single-cell RNA-seq reveals at least two distinct cell populations in differentiating 
preadipocytes into adipocytes 
To determine the cell clusters in adipogenesis, primary human abdominal 
subcutaneous preadipocytes were seeded at 100% or 80% confluency and 
treated with an adipogenic cocktail for up to 14 days (Soumillon et al., 2014). For 
each day, cell cultures were trypsinized, sorted into 384-well plates by flow 
cytometry such that a single well had a single cell, and lysed to extract RNA for 
sequencing. We performed Pathway and Gene Set Overdispersion Analysis 
(PAGODA) in order to determine the optimal cell clustering (Fan et al., 2016). 
The t-SNE plots revealed at least two distinct clusters in the 7-day differentiation 
beginning at 100% confluency (Figure 18A). Preadipocytes at day 0 (black) 
largely clustered into a single group. However, at day 3 (pink), the differentiating 
preadipocytes separated into two distinct clusters and this separation remained 
evident in preadipocytes at day 7 (red). 
 
The 14-day differentiation experiment beginning at 80% confluency showed that 
the preadipocytes at day 0 (black) clustered into two separate groups (Figure 
18B). At the early stages of differentiation in days 1-3 (pink), the preadipocytes 
showed similar, though less distinct, clusters as day 0. At the intermediate stages 
of differentiation in days 5 and 7 (red), the clustering remained consistent with 
the early stages of differentiation. In the late stages of differentiation in days 9 
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and 14 (dark red), the preadipocytes clustered into groups similar to the 
intermediate stages. The differentiation experiment beginning at 100% 
confluency showed greater separation in the late days of differentiation, whereas 
the differentiation beginning at 80% confluency showed greater separation in the 
early days of differentiation. 
 
In order to determine the genes driving the heterogeneity in the gene expression 
profiles, PAGODA identified a small set of gene signatures clusters associated 
with the transcriptional heterogeneity during adipogenesis in the 7-day 
experiment (Figure 19A). The gene signature with the highest proportion of 
variance in the 7-day experiment were largely lowly-expressed genes that 
marked preadipocytes and contained genes such as Mitogenic-Activated 
Proteins Kinase (MEK1), Syntaxin 8 (STX8), and Apoptosis Antagonizing 
Transcription Factor (AATF) (Figure 19B). The second highest ranking gene 
signature marked adipocytes and contained genes such as Fatty Acid Binding 
Protein 4 (FABP4), Platelet-Derived Growth Factor Receptor Alpha (PDGFRα), 
and Membrane Metallo-Endopeptidase (MME) (Figure 19C). The third highest 
ranking gene signature marked at least two groups within preadipocytes and day 
7 adipocytes and contained genes such as Cluster of Differentiation 84 (CD84), 
Zinc Finger Protein 490 (ZNF490), and Glycerol Kinase 5 (GK5) (Figure 19D). 
 
  
148 
In the 14-day experiment, PAGODA identified several gene signatures that 
captured different aspects of heterogeneity, although one gene signature had a 
much higher proportion of variance than the other clusters (Figure 20A). The 
highest-ranking gene signature marked cells across nearly all days of 
differentiation and contained several ribosomal and structural proteins such as 
RPL31, VIM, and COL1A1 (Figure 20B). The second highest ranking gene 
signature contained several metallothionein genes and largely differentiating cells 
post day 0 (Figure 20C). The third highest ranking gene signature contained 
genes in histones and marked cells in early differentiation (day 0 and day 1) 
(Figure 20D). Thus, the highest-ranking gene signatures in both the 7-day and 
14-day experiment demarcated either preadipocyte or adipocytes 
 
Distinct populations of cells in differentiating subcutaneous preadipocytes are 
associated with stage-specific phenotypical differences in cell growth, 
extracellular matrix, and oxygen consumption  
In order to determine the genes associated with clusters observed on the t-SNE 
plots, we performed differential gene expression between the left and right 
cluster for each day of analysis. First, the 7-day experiment beginning at 100% 
confluency in the preadipocytes (day 0), differential expression analysis between 
the two cell clusters produced genes primarily related to protein synthesis (Figure 
21A). At day 3, the separation was primarily driven by genes involved in 
remodeling the extracellular matrix (Figure 21B). Finally, at day 7, the previous 
  
149 
differences in gene expression remained and additional genes related to 
metabolism appeared. These include gene sets related to oxygen consumption 
and protein metabolism (Figure 21C). Each of these metabolic gene sets were 
higher in the right cluster (red), suggesting that these are more metabolically-
active cells. 
 
In the 14-experiment, the early days of differentiation (days 0, 1, and 2), the most 
robust differences in gene expression were genes involved in cell cycle and 
growth, although none of the differences at day were statistically significant 
(Figures 22A). The intermediate days (days 3, 5, and 7) retained the differences 
in protein synthesis-related pathways and saw the emergence of metabolism-
related pathways (Figure 22B). Lastly, the late days of differentiation (days 9 and 
14) showed the most robust differences in metabolic gene sets (Figure 22C). 
Specifically, the left cluster had higher expression of genes involved in oxygen 
consumption and protein metabolism. 
 
Differentiating preadipocytes are associated with genes correlated to 
extracellular acidification and glucose uptake 
Both the 7-day and 14-day experiment both showed a similar pattern of early 
growth-related differences and late metabolic differences. Several reported 
markers of adipocytes or preadipocyte differentiation were not differentially 
expressed between the clusters such as FABP4, Ataxin 1 (ATXN1; human 
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homolog of Sca1), and PDGFRα (Figure 23). The right cluster, compared to the 
left cluster, also showed higher expression of TBX15, which has previously been 
shown to be a marker of glycolytic adipocytes in mice (Lee et al., 2017). 
Importantly, there was no differential expression or no detection of the markers of 
beige or brown adipocytes including TMEM26 or UCP1.  
 
To corroborate these gene expression differences, we sought to determine 
whether white preadipocytes from a single adipose depot clustered by metabolic 
phenotypes. A total of 36 clonally-expanded white preadipocytes from human 
neck white subcutaneous tissue were generated as previously described (Xue et 
al., 2015). Gene expression profiles were generated by RNA-seq and analyzed 
with PAGODA. Principal component analysis reveals at least two clusters with 
the 36 clonally-expanded cell lines (Figure 24A). The gene sets capturing 
significant aspects of heterogeneity reflected differences in cell adhesion 
(GO:0034330), response to type I interferon (GO:0071357), and RNA processing 
(GO:0006396) (Figure 24B). The genes within these aspects, such as MX 
dynamin like GTPase 1 (MX1) and Integrin Subunit Alpha 2 (ITGA2), suggested 
sub-clusters within both cluster A and B (Figure 24B).  
 
Phenotypic profiling was performed on each clone to obtain profiles in 
extracellular acidification (ECAR), oxygen consumption (OCR), glucose uptake, 
and adipogenic capacity (PPARG expression after differentiation) (Figure 24B). 
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The phenotype profiles were correlated to the five significant aspects to show 
that GO:0071357 was associated with glucose uptake, whereas the other 
aspects have no significant correlation (Figure 24C). Comparing the seven most 
extreme members in the gene expression of cluster A against the seven most 
extreme members of cluster B showed a difference in glucose uptake in PPARG 
expression of differentiation into adipocytes (Figure 24D).  
 
To integrate the clonal gene expression data, phenotype-gene correlation vectors 
were created between every gene and each measured phenotype (Figure 24E). 
These gene-phenotype correlations were examined in the single-cell data to 
determine whether any gene signatures would preferentially mark any of the 
clusters during differentiation. The results show that the clusters showed 
differences in the expression of genes correlated to extracellular acidification and 
glucose uptake at day 0, 3, and 7 (Figure 25A-C). These results suggest that the 
clusters in the single-cell data in are defined by metabolic differences, primarily 
those associated with extracellular acidification and oxygen consumption. 
 
Subnetwork detection revealed an early activated network of zinc finger proteins 
in differentiating preadipocytes that is maintained in adipogenesis-resistant cells 
As adipogenesis is driven by a regulated set of a transcriptional programs, we 
sought to determine gene modules in the single-cell data potentially related to 
differentiation. We developed a new variant of an algorithm to detect highly-
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activated genes that code for connected protein-protein interaction networks and 
transcriptional complexes in single-cell data. Each run of the algorithm after a 
random initialization would generate a single protein network. After several runs 
to generate multiple protein networks, only three distinct proteins networks were 
returned: 1) The ribosome, 2) the ubiquitin-proteasome complex, and 3) an 
uncharacterized protein network found in one of the clusters expressed the 
detected module (Figure 26A). This gene module consisted of 80 genes 
connected in the pan-network as defined from Pathway Commons v5 (Figure 
26B) (Cerami et al., 2011). These genes were enriched KRAB domains and 
C2H2 zinc finger regions (Figure 26C), which are typically nucleic acid binding 
proteins. 
 
This module had a small tightly-connected subnetwork consisting of largely-
uncharacterized zinc finger proteins (ZNFs). In the top 100 cells with the detected 
module over the time-course of adipogenesis, several of these ZNFs (ZNF264, 
ZNF490, ZNF587, and ZNF714) decreased as the level of expression of FABP4, 
a marker of adipocyte differentiation, increased (Figure 26D). Interestingly, the 
ZNF cluster did not significantly vary in the gene expression profiles of multi-
cellular preadipocyte cultures across the time course of preadipocyte 
differentiation into adipocytes (Figure 26E). As the ZNF module is only detected 
at the single-cell level and not at the multi-cellular population level, the module 
may be found in a rare population of preadipocytes. 
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To determine whether these ZNFs may be specific to the adipocyte cell fate, we 
examined a single-cell differentiation study in adipogenesis, osteogenesis, and 
chondrogenesis (Islam et al., 2011). The results show that ZNF264, ZNF490, 
ZNF587, and ZNF714 are lower at day 7 in adipogenesis compared to day 0, 
consistent with our results (Figure 27A). Cells undergoing chondrogenesis show 
a time-dependent decrease in only ZNF490, whereas ZNF264, ZNF587, and 
ZNF714 are not differentially expressed between day 7 and day 0 of 
chondrogenesis (Figure 27B). Cell undergoing osteogenesis showy ZNF714 
decreasing in day 7 compared to day 0 (Figure 27C), ZNF587 is not differentially 
expressed at day 7 compared to day 0, and ZNF264 and ZNF490 are not 
expressed at either day 7 or day 0. Taken together, these results suggest that 
the detected module may be coordinately expressed in the formation of 
adipocytes, although ZNF490 and ZNF714 may be involved in the formation of 
chondrocytes and osteocytes. 
 
Knockdown of ZNF284, ZNF490, ZNF587, and ZNF714 may accelerate lipid 
accumulation during differentiation in subcutaneous preadipocytes 
Given that the expression of the ZNF module was higher in undifferentiated 
preadipocytes, we sought to determine whether knockout of the ZNFs would 
enhance or accelerate adipogenesis. We performed CRISPR knocked out of 
ZNF264, ZNF490, ZNF587, ZNF714, or all four concurrently in preadipocytes 
before adipogenesis. The results show that lipid accumulation at day 20 was 
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neither affected nor decreased after knocking down ZNF490 or ZNF714 (Figure 
28A). However, examining an earlier day of differentiation, day 14, revealed that 
each knockout increased lipid accumulation compared to the control (Figure 
28B). Thus, knocking out these genes may accelerate the initial to intermediate 
stage of adipogenesis, but not the terminal fate. 
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Discussion 
The heterogeneity of white adipocytes is an ongoing question previously 
hindered by technological challenges (e.g. large adipocytes) or relied on 
predefined markers. Here, we analyzed single-cell RNA-seq of human 
subcutaneous preadipocytes undergoing differentiation into white adipocytes. 
The results show the presence of at least two distinct clusters of cells in both the 
preadipocyte and adipocyte stage. Differential gene expression reveals that the 
early differentiation differences were due to genes related to cell cycle, protein 
synthesis, and growth-associated pathways. Late-stage differences are primarily 
due to genes related to oxygen consumption, which were also confirmed by 
phenotypic profiling in clonally-derived white preadipocyte cell lines. Lastly, a 
subset of cells within one of the clusters is marked by the activation of a set of 
zinc finger proteins, potentially alluding to a pool of adipocyte precursors 
resistant to adipogenesis. 
 
One of the most remarkable gene expression differences between the two single-
cell experimental designs can be attributed to the starting confluency (experiment 
D1 at 80% confluency and experiment D3 at 100% confluency). The t-SNE plots 
distinctly show the differentiation of confluent preadipocytes have more 
separation in the late stages of differentiation, whereas the differentiation of sub-
confluent preadipocytes have more separation in the early stages of 
differentiation. Despite this difference, both experimental designs show two 
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distinct clusters of cells during differentiation. Moreover, a similar time-dependent 
trend is observed comparing the two clusters within each experiment: the early 
stages of differentiation have differences in cell growth and the late stages of 
differentiation have differences in oxidative metabolism. Although, the 
intermediate stages of differentiation are rather different as the confluent 
differentiation experiment has enriched gene sets related primarily to 
extracellular matrix remodeling, whereas the sub-confluent differentiation has 
enriched gene sets in cell growth and oxidative metabolism.  
 
Previous research in mouse models have identified subpopulations of 
preadipocytes marked by the expression of certain genes such as Sca1 and 
Myf5 (Shan et al., 2013). It was also shown that different fat depots had different 
proportions of these Sca1+ or Myf5+ subpopulations. For example, 
preadipocytes derived from a Myf5+ lineage comprised 9% of perigonadal white 
adipose tissue and as much as 50% of anterior subcutaneous white adipose 
tissue (Sanchez-Gurmaches and Guertin, 2013). Additional studies found that 
knocking out PTEN in Myf5+ cells resulted in lipodystrophy (Sanchez-Gurmaches 
et al., 2012), suggesting that these different preadipocyte populations have a 
functional importance and could serve as important therapeutic targets. In our 
study, Myf5 and the human homolog of Sca1, ATXN1, were not detected in any 
cells, indicating these murine markers do not label human white abdominal 
preadipocytes  
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In contrast to murine studies, limited studies regarding human preadipocyte 
heterogeneity have relied on pre-defined surface marker expression to enrich for 
subpopulations in adipose tissue (Li et al., 2011; Rada et al., 2011; Ussar et al., 
2014). These cell surface proteins for cell sorting are derived from stem cell 
studies, where these proteins typically mark a common stem cell population (e.g. 
CD34+) or a developmental lineage (e.g. CD31-). Subsequent characterization of 
these subpopulations revealed phenotypic differences such as growth rate and 
differentiation potential. In one study, preadipocytes sorted based on their 
expression of the markers CD31, CD34, CD146, CD90, and CD45 showed that 
CD34+/CD31- preadipocytes are the population with the highest adipogenic 
potential (Li et al., 2011).  
 
One of the challenges in integrating these results is the differences across 
studies of pre-defined markers. For example, one definition of preadipocytes 
involved the panel of markers CD29, CD44, CD49d, CD73, CD90, CD105, Stro-1 
and p75 (Rada et al., 2011). These preadipocyte populations were shown to 
have distinct predispositions to either chondrogenesis or osteogenesis. In 
another study, the marker panel of CD3, CD4, CD8, CD11c, CD14, CD19, CD25, 
CD31, CD34, CD45, CD127, and CD206 was used to sort stromal vascular cells 
before sequencing. The single cell gene expression profiling of these sorted 
subcutaneous adipose stromal vascular fraction suggested the bulk of cellular 
heterogeneity was defined by preadipocytes and different types of macrophages 
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(Acosta et al., 2017), but does not address the question of heterogeneity in 
adipocytes. Our study sorted for many of the same preadipocyte markers (see 
methods), but what is more important is that we also analyzed preadipocytes 
during white adipocyte differentiation. 
 
White adipocytes, once thought to be a single-cell type, may be comprised of 
metabolically-distinct cell types separate from the more well-characterized brown 
and beige adipocytes. Developmental genes have been show to mark different 
populations of preadipocytes (Gesta et al., 2007). For example, TBX15 has been 
shown to be a marker of glycolytic white adipocytes in murine adipose tissue 
(Lee et al., 2017). Indeed, one of the genes showing cluster-specific expression 
was TBX15. Interestingly, the same cluster had even higher expression of 
HOXC10, which has been shown to inhibit browning in white adipose tissue and 
has higher expression in subcutaneous adipose tissue compared to visceral 
adipose tissue (Brune et al., 2016; Ng et al., 2017). The other cluster, however, 
did not have a statistically-significant developmental gene. Although, the 
expression of PDGFC was higher in this cluster. The receptor of PDGFC, 
PDGFRα, has been shown to label preadipocytes (Berry et al., 2014) and may be 
involved promoting beige adipocyte development over white adipocyte 
development (Gao et al., 2018). Thus, at least one identified cluster of adipocytes 
may be marked by TBX15 and HOXC10. 
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Zinc finger proteins are one of the largest families of DNA-binding proteins 
(Weirauch and Hughes, 2011). The zinc finger proteins ZNF264 and ZNF490 
have been shown to be DNA-binding (Schmitges et al., 2016). Additionally, the 
expression of ZNF714 is higher in visceral adipose tissue from insulin-resistant 
obese populations compared to insulin-sensitive obese populations (Crujeiras et 
al., 2016), which, given our data, may be due to a higher abundance of 
uncommitted, differentiation-resistant cells. While the knockout of any of the 
ZNFs did not largely affect the lipid accumulation by day 20, the lipid 
accumulation by day 14 was increased. In the context of adipose tissue biology, 
a small pool of preadipocytes resistant to differentiation can be useful in the face 
of unknown metabolic demands; for example, to avoid adipogenesis after a 
transient increase in nutrient supply or pro-differentiation signals. Such hedging 
approaches in fluctuating environments are commonly found in biological 
systems (Kussell, 2005; Levy et al., 2012; Cerulus et al., 2016). Several earlier 
studies have made observations consistent with at least two types of 
preadipocytes defined by several differences including adipogenic capacity, 
replicative capacity, and apoptosis susceptibility (Tchkonia et al., 2005; Prunet-
Marcassus et al., 2006). Thus, these ZNFs may be involved in the transcriptional 
regulation of white adipocyte differentiation. 
 
Previous work in systems biology developed numerous methods to model a 
biological system as a linear system (Bergman et al., 1979; Jeong et al., 2001; 
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Orth et al., 2010). In the context of gene expression, this framework intuitively 
implies that each gene in a system is a gate whose output can be modeled as 
linear combination of outputs of other gates with some error. While solving such 
systems is relatively tractable, the noise, complexity and lack of linearity in 
biological systems made these efforts challenging. In this paper, we introduce a 
useful technical insight to integrate biological intuitions with computational 
modeling. Instead of assuming the entire system is linear we assume that the 
system is both piecewise simple and relatively modular. That is, it can be 
decomposed into connected network modules where within each module the 
system can be modelled by a low dimensional linear factorization. The advent of 
modern data science and machine learning opens the door to a plethora of novel 
methods utilizing such algebraic decompositions. 
 
In summary, we have provided evidence of the presence of at least two types of 
human white subcutaneous adipocytes. These adipocytes show large differences 
in metabolic gene sets and are not accounted for by the presence of beige fat. 
We have also shown that a subset of preadipocytes are marked by the 
expression of a ZNF network, which may be involved in regulation white 
adipocyte differentiation. Thus, these types of white adipocytes may have 
important physiological consequences in adipose tissue and whole body 
metabolism. 
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Figures  
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Figure 18 PAGODA and t-SNE reveals at least two clusters in differentiating 
preadipocytes. Single-cell RNA seq was performed on differentiating 
preadipocytes beginning at either 100% or 80% confluency and differentiated for 
up to 14 days. PAGODA was used to determine the optimal cell clustering based 
on the genes driving the heterogeneity. The result was plotted by t-SNE. (A) 
Differentiating preadipocytes beginning at 100% confluency show two distinct 
clusters of cells at day 3 and day 7. (B) Differentiating preadipocytes beginning at 
80% show two distinct clusters of cells most evident at day 0. 
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Figure 19 PAGODA suggests a few significant gene sets drive the 
transcriptional heterogeneity in differentiating preadipocytes beginning at 
100% confluency. Single-cell expression profiles in experiment D3 were 
analyzed to determine the genes and pathways driving the heterogeneity. 
PAGODA was used to perform weighted principle component analysis on pre-
defined (e.g. Gene Ontology terms) and de novo gene sets. The gene sets were 
scored on their significance. Correlated gene sets were coalesced in order to 
reduce redundancy. (A) The heatmap of the significance gene sets shows a few 
de novo gene sets captured major aspects of heterogeneity. (B) The highest-
ranking gene set had the highest-expressing cells in several day 0 
preadipocytes. (C) The second highest-ranking gene set had the highest-
expressing cells in day 3 and day 7 differentiating preadipocytes. (D) The third 
highest-ranking gene set had the highest-expressing cells in day 0 
preadipocytes. 
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Figure 20 PAGODA suggests one predominate gene set drives the 
transcriptional heterogeneity in differentiating preadipocytes beginning at 
80% confluency. Single-cell expression profiles in experiment D1 were analyzed 
to determine the genes and pathways driving the heterogeneity. PAGODA was 
used to perform weighted principle component analysis on pre-defined (e.g. 
Gene Ontology terms) and de novo gene sets. The gene sets were scored on 
their significance. Correlated gene sets were coalesced in order to reduce 
redundancy. (A) The heatmap of the significance gene sets shows a few de novo 
gene sets captured major aspects of heterogeneity. (B) The highest-ranking gene 
set had the highest-expressing cells covering all days of differentiation. (C) The 
second highest-ranking gene set had the highest-expressing cells in the 
intermediate days of differentiation (days 3, 5, 7). (D) The third highest-ranking 
gene set had the highest-expressing cells in early days of differentiation (days 0, 
1, and 2). 
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Figure 21 Differential gene expression shows day-specific enrichment of 
pathways between the two clusters of differentiating preadipocytes. 
Differential gene expression was performed between the left (blue) and right 
(red) cluster for each day of differentiation in differentiating preadipocytes 
beginning at 100% confluency. Gene set enrichment analysis was performed on 
the differentially expressed genes and the top 10 up and down pathways sorted 
by z-score are shown for each day. The numbers next to the bars indicate the 
false discovery rate (FDR). (A) At day 0, the genes in the right cluster were 
related to several gene sets involving protein translation, whereas the left cluster 
had no significant gene sets (FDR < 0.25). (B) At day 3, the right cluster had 
several gene sets related to extracellular matrix remodeling, whereas the left 
cluster had one significant gene set in fructose metabolism. (C) At day 7, the 
right cluster had gene sets encompassing several different pathways including 
pathways in metabolism (e.g. TCA cycle and respiratory electron transport). The 
left cluster had no statistically-significant gene sets. 
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Figure 22 Differential gene expression shows stage-specific enrichment of 
pathways between the two clusters of differentiating preadipocytes. 
Differential gene expression was performed between the left (shades of blue) 
and right (shades of red) clusters for each day of differentiation in differentiating 
preadipocytes beginning at 80% confluency. Gene set enrichment analysis was 
performed on the differentially expressed genes and shown are summarized 
representative five up and down pathways for three major stages of 
differentiation. The numbers in the heatmap indicate the false discovery rate 
(FDR). (A) At the early stages of differentiation (days 0, 1, and 2), the right 
clusters were enriched in pathways related to G-protein coupled receptor binding. 
The left clusters were enriched in pathways related to RNA metabolism. (B) At 
the intermediate stages of differentiation (days 3, 5, and 7), the right clusters 
were enriched in pathways related to protein synthesis. The left clusters had no 
enriched pathways (FDR <0.25). (C) In the late stages of differentiation (days 9 
and 14), the right clusters were enriched in the telomerase pathway. The left 
clusters were enriched in several metabolic gene sets including glycolysis, 
respiratory electron transport, and glucose metabolism. 
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Figure 23 TBX15 may mark the right cluster of adipocytes. Differential gene 
expression was performed between the left and right cluster of day 7 adipocytes 
in experiment D3. The genes shown are previously-studied adipocyte markers for 
lineage or differentiation stage. For each gene, the maximum likelihood estimate 
and 95% confidence interval of the log2 expression ratio (right cluster over left 
cluster) is show. The brown adipocyte markers MYF5 and UCP1 were not 
detected in any cells. FDR = False Discovery Rate. 
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Figure 24 Clonal preadipocyte cell lines cluster into distinct metabolic 
signatures. RNA seq was performed on 36 (9 clones each from 4 subjects) 
clonally expanded immortalized human neck white subcutaneous preadipocytes 
and analyzed with PAGODA. (A) Principal Component Analysis of subject-
corrected gene expression profiles. Affinity Propagation suggested at least 2 
clusters within the clones (B) Top gene sets capturing significant aspects of 
transcriptional heterogeneity among the 36 clones. Each of these aspects had 
several genes marking potential sub-populations of clones within the clusters. 
Basal oxygen consumption (OCR) and basal extracellular acidification rate 
(ECAR) were measured in preadipocytes via the Seahorse XF Analyzer. Glucose 
uptake was measured with radiolabeled 2-deoxy-glucose in preadipocytes. The 
levels of PPARG was measured after 18 days of differentiation. (C) The four 
phenotypes were correlated (Pearson) to the five significant aspects. (D) The 
seven most extreme members (by Ward’s method) of cluster A compared against 
the seven most extreme members of cluster B show differences in glucose 
uptake and differentiation capacity. (E) The four phenotypes were correlated 
(Spearman) to every gene in the clones to generate phenotype correlation 
vectors. The top ten genes for each phenotype are shown as a heatmap. 
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Figure 25 Single cells during adipogenesis marked by genes correlated to 
extracellular acidification and glucose uptake in clonal preadipocyte cell 
lines. RNA-seq was performed on 36 clonally-expanded white preadipocyte cell 
lines derived from human subcutaneous neck white adipose tissue. These gene 
expression profiles were correlated (Pearson) to measured phenotypes in Figure 
24. The four phenotype correlation vectors (oxygen consumption, extracellular 
acidification, glucose uptake, and PPARG expression after differentiation) were 
then correlated (Spearman) to the single-cell gene expression profiles for each 
cluster. The distribution of correlation coefficients was compared between the left 
and right cluster for each day. In each day (A-C), the left and right cluster show 
significant differences in extracellular acidification and glucose uptake. Asterisks 
indication FDR <= 0.05 as assessed by an ANOVA. 
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Figure 26 Subnetwork detection reveals a cluster of ZNFs in adipogenesis. 
Single cell gene expression profiles in the 14-day experiment (80% confluency) 
were transformed to z-scores before network detection. (A) The subnetwork 
detection algorithm was used to reveal a set of cells primarily found in the left 
cluster. (B) The detected subnetwork had 80 connected genes. (C) Pathway 
enrichment revealed these 80 genes were enriched in KRAB domains and C2H2 
zinc fingers. (D) The max expression of the ZNFs (ZNF264, ZNF490, ZNF587, 
and ZNF714) in the detected cells showed a negative correlation to the 
adipogenic marker FABP4. (E) RNA-seq of whole preadipocyte cultures during 
differentiation show that the ZNFs do not decrease over time. Bars indicate mean 
± s.e.m. 
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Figure 27 ZNFs may be specific to the adipogenic mesodermal cell fate. 
RNA seq expression profiles generated during the differentiation of fibroblasts 
into adipocytes, chondrocytes, or osteocytes were obtained from  (Islam et al., 
2011). The expression of ZNF264, ZNF490, ZNF587, and ZNF714 show lineage-
specific regulation during differentiation. (A) Adipogenesis shows higher 
expression of the ZNF cluster in the undifferentiated state (day 0) compared to 
day 7 (T7). (B) Chondrogenesis suggests a time-dependent decline in ZNF490 
but not other ZNFs. (C) Likewise, osteogenesis suggests downregulation of the 
ZNF cluster (barring ZNF587) over time. Bars indicate mean ± s.e.m. 
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Figure 28 Knockout of ZNFs accelerates adipogenesis by day 14 and not 
day 20. Immortalized human neck subcutaneous white preadipocytes were 
transduced with CRISPR plasmids targeting ZNF264, ZNF490, ZNF587, or all 
four ZNFs at once. Transduced preadipocytes were subjected to an adipogenic 
cocktail for up to 20 days before fixation and lipid staining. (A) Lipid accumulation 
in late-stage adipocytes (day 20) was largely unaffected by the knockouts with 
the exception of ZNF490 and ZNF714, which decreased lipid accumulation. (B) 
Intermediate stage (day 14) adipocytes, however, showed an increase in lipid 
accumulation in each knockout. Asterisks indicate p < 0.05 via Student’s t-test. 
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